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 ABSTRACT 
 Vital cellular processes such as nutrient uptake, receptor signaling, and 
cell migration are controlled by a balance between cell surface receptor 
internalization and recycling. Clathrin-mediated endocytosis is the major 
mechanism of receptor internalization in which cargo-enriched endocytic vesicles 
form at, and are released from, the plasma membrane before maturing into early 
endosomes. The receptors can then be sorted into fast and slow recycling 
pathways that replenish receptor levels at the cell surface. A major fast recycling 
pathway is controlled by the small GTPase Rab4a, which plays a central role in 
cell migration and cancer cell invasion through regulation of integrin αvβ3 
recycling. 
 Recent studies have discovered a family of clathrin-coated vesicle 
proteins, known as adaptin-ear-binding coat-associated proteins (NECAPs), that 
consists of two family members, NECAP1 and NECAP2. NECAP1 functions in 
endocytosis and cooperates with the clathrin adaptor AP-2 to control endocytic 
vesicle size, number and cargo. Importantly, NECAP2 did not rescue the knock-
down phenotype of NECAP1, revealing that NECAPs are not functionally 
  vii
redundant. The studies described in this dissertation show that NECAP2 controls 
the fast recycling of epidermal growth factor receptor and transferrin receptor. 
Furthermore, NECAP2 specifically functions in Rab4a-mediated fast recycling 
together with the clathrin adaptor AP-1. In contrast, NECAP2 has no effect on 
AP-1-mediated transport from the Golgi or on other Rab4a-dependent sorting 
events that utilize additional clathrin adaptors and effector proteins. Thus, 
NECAP2 regulates a sub-route within the Rab4a recycling pathway and, in fact, 
is the first protein known to date to show this level of specificity. NECAP2 knock-
down revealed that this sub-route controls cell migration and cancer cell invasion. 
Specifically, NECAP2 knock-down impaired the recycling of integrin αvβ3 to the 
cell surface, leading to decreased Rac1 activation and integrin αvβ3-dependent 
persistent cell migration. NECAP2 depletion also alleviated the inhibitory effect 
on integrin α5β1 recycling, switching cells to integrin α5β1-dependent cell 
migration. Notably, loss of NECAP2 function in breast cancer cells inhibited 
invasive migration in a 3D invasion model system. Therefore, the NECAP2 
pathway may provide a therapeutic target, in particular for the 25% of breast 
cancers with amplification of Rab4a. 
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 CHAPTER I - INTRODUCTION 
Eukaryotic cells use membrane bound compartments, also called 
organelles, to separate specialized processes. Each of these compartments 
contains defining features such as resident proteins and phospholipids that 
convey identity and function. For example, phosphatidylinositol 4-phosphate 
(PI(4)P) is found predominantly at the Golgi while PI(4,5)P2 and PI(3)P are 
markers of the plasma membrane and endosomes, respectively (1).  
To maintain their normal function, cells continuously need to exchange 
material in between organelles without altering the composition or function of the 
donor and acceptor compartment. To do so, mammalian cells use a complex 
network of intracellular transport pathways that allow for the directional transport 
of material in between compartments (Fig. 1.1). For example, newly synthesized 
cell surface proteins traffic from the endoplasmic reticulum (ER) to the Golgi to 
the plasma membrane, while activated signaling receptors are internalized from 
the plasma membrane and sent to late endosomes and lysosomes for 
degradation to terminate cell signaling events. 
The common feature in each pathway is that proteins and other cargo 
molecules are concentrated into small vesicular or tubular carriers that bud off 
the donor organelle and then fuse with the target compartment to deliver their 
cargo content. Notably, a lot of transport pathways converge within the 
endosomal system, and in particular in early endosomes (EEs), which are 
marked by early endosome antigen 1 (EEA1) and PI(3)P (2). EEs continuously 
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Figure 1.1 – Clathrin-mediated transport. Receptors at the plasma membrane are concentrated by endocytic 
proteins such as AP-2 in a clathrin-coated pit during vesicle formation. The cargo-containing vesicle buds off the 
cell surface through dynamin-mediated scission. After shedding its clathrin coat the endocytic vesicle matures into 
an early endosome marked by EEA1. From this compartment cargo is sorted into a number of routes: 1) Cargo is 
recycled back to the plasma membrane through formation of recycling endosomes in the slow, Rab4b- and Rab11-
mediated recycling pathway or through recycling tubules involved in various fast recycling pathways controlled by 
Arf6, Rab35, and Rab4a; 2) Cargo is returned to the Golgi through retrograde transport; 3) Luminal cargo is 
retained in EEs as they mature into late endosomes and MVBs to promote lysosomal degradation. Key 
phospholipids involved in organelle identity and in the regulation of cargo transport are indicated in grey.
 3 
receive material from endocytic and biosynthetic pathways and subsequent 
sorting decisions determine cargo fate. A variety of transport pathways originate 
from EEs that sort cargo from the luminal domain into tubular extensions and 
carriers for transport towards the Golgi or the plasma membrane (3). In contrast, 
membrane-associated proteins and soluble cargo that remain in the EE lumen 
enter the degradative pathway when EEs convert into multi-vesicular bodies 
(MVBs) and finally, lysosomes (4).  
Changes in intracellular transport provide a means to dynamically alter cell 
function. For example, changes in cadherin and integrin recycling to the cell 
surface alter the composition of the cell surface proteome and allow cells to 
transition between cell-cell adhesion and cell migration (5). Furthermore, 
misregulation of intracellular transport pathways directly contributes to a wide 
range of human diseases including diabetes, neurodegenerative diseases and 
cancer (6–9). Defining the molecular mechanisms that govern individual transport 
pathways is an essential pre-requisite for understanding their importance for cell 
physiology and in pathology. However, our limited insights into the regulation of 
most sorting pathways impedes our understanding of the proteins and 
mechanisms underlying common diseases. 
 
Clathrin-mediated endocytosis (CME) 
 Clathrin-mediated endocytosis (CME) serves as the major entry 
route for cell surface proteins and extracellular ligands into mammalian cells, and 
 4 
is the best understood transport pathway to date. CME serves numerous 
essential cell functions including nutrient uptake, ligand-activated cell signaling, 
cell differentiation, neuronal transmission, and cell migration (10). The core 
feature of CME is the formation of cargo-enriched clathrin-coated vesicles 
(CCVs), a highly coordinated multi-step process that involves initiation of clathrin 
coat formation, localized membrane deformation, cargo selection and 
concentration in the forming vesicle, continued clathrin coat assembly, vesicle 
fission, and finally removal of the clathrin coat to allow for subsequent vesicle 
transport and fusion with the target organelle (10).  
The complete cycle of CCV formation occurs in about one minute (11). 
Despite this short timeline, CME relies on a complex protein network of about two 
dozen proteins that must work in concert for the formation of a cargo-containing 
CCV (10). Some proteins such as clathrin and the endocytic clathrin adaptor 
protein 2 (AP-2) are involved in multiple/all aspects of vesicle formation. 
However, most components of the endocytic protein machinery, so-called 
accessory proteins, only participate in select steps and thus need to be recruited 
to the forming vesicle in an coordinated manner (11). On the molecular level, the 
endocytic protein machinery is organized by protein-protein interactions that 
depend on the ability of a folded protein domain in one protein to interact with a 
specific peptide motif presented in the unstructured regions of another protein. 
Notably, these domain/peptide interactions are of low affinity in isolation. 
However, during vesicle formation, each coat component engages in multiple 
 5 
different interactions that collectively stabilize the forming coat and push vesicle 
formation toward completion (12). 
 
Clathrin 
Clathrin forms a lattice around the curved membrane of a forming 
endocytic vesicle. This lattice is formed through the polymerization of clathrin 
triskelia, with each triskelion containing three clathrin heavy chains (CHCs) (13) 
as well as associated clathrin light chains (Fig. 1.2), of which there are two 
isoforms in mammalian cells (CLCa/CLCb) (13). The N-terminus of CHC is 
known as the terminal domain and contains a β–propeller composed of seven 
WD40 domains (13). The terminal domain is the major interface through which 
clathrin interacts with AP-2 and other endocytic proteins. Distinct binding sites on 
the terminal domain fold mediate binding to clathrin box peptide motifs, 
LΦXΦ[DE] (where Φ is a bulky hydrophobic amino acid), PWDLW, and DLL (14), 
present in protein binding partners. The terminal domain is attached to a chain of 
42 α-helices that form a bent-shaped “leg”, followed by the “hub” formed by a 
larger α-helix that participates in assembling CHCs into triskelia, and a less 
defined 45-amino acid C-terminus (13, 15). Notably, clathrin does not directly 
interact with lipids or other membrane components. Instead, clathrin relies on 
interactions with clathrin adapters and accessory proteins for recruitment to the 
sites of vesicle formation (16, 17). 
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Figure 1.2 - Clathrin. Clathrin is a molecular scaffold for vesicular formation. (A) 
The functional unit of clathrin is the triskelion, in which three clathrin heavy 
chains (CHC) connect through their C-terminal hub domains to form the 
characteristic tri-legged structure. The N-terminal domain of each CHC serves as 
a major binding interface for AP-2 and endocytic accessory proteins. CHC aso 
associates with clathrin light chains. (B) Triskelia assemble to form a clathrin 
lattice around a forming vesicle.   
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Adapter protein 2 
AP-2 is the only member of the five-member assembly polypeptide family 
that functions in endocytosis. All family members are heterotetrameric protein 
complexes that show high structural similarity despite a low degree of 
conservation on the amino acid level. AP-2 is composed of two large subunits, α- 
and β2-adaptin, as well as one medium (μ2-adaptin) and one small subunit (σ2-
adaptin) (Fig. 1.3). The small and medium adaptin subunits together with the N-
terminal regions of the two large adaptins form a large folded domain called the 
trunk, which targets AP-2 to the plasma membrane through interactions with 
PI(4,5)P2 as well as cargo proteins that display tyrosine-based (YXXØ) and 
dileucine-based ([DE]XXXL[LI]) peptide motifs in their cytoplasmic tails (18). The 
N-terminal regions of the large adaptin subunits form globular domains, referred 
to as the α- and β2-ears (or appendages), respectively, that mediate interactions 
with accessory proteins and clathrin. The ears connect to the trunk through 
flexible linkers, and the β2-linker contributes to clathrin recruitment and assembly 
into the clathrin lattice.   
The α- and β2-ears are bi-lobed, containing a distal platform and a 
proximal sandwich subdomain that connects to the linker region of the large 
adaptin subunits (10, 18, 19). Each subdomain contains binding sites for protein-
protein interactions. Specifically, the platform subdomain of the α-ear binds 
accessory proteins containing DPF/W and FxDxF peptide motifs while the 
sandwich domain binds to WxxF-acidic motifs (20, 21). Notably, the α-ear is the 
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Figure 1.3 - Clathrin Adaptors. Formation of a clathrin coat involves several clathrin adaptors. AP-2 and AP-1 are 
heterotetrameric complexes composed of α-, β2-, µ2, and ơ2-subunits and γ-, β1-, µ1-, and ơ1-subunits, 
respectively. All for subunits contribute to the trunk region, which targets the adapter complex to the membrane by 
binding to phospholipids as well as cargo. Membrane recruitment of AP-1 also depends on binding to active, GTP-
bound Arf1. Clathrin binds to the ear and linker regions of the β-subunits. The α-ear and γ-ear bind to accessory 
proteins to control vesicle formation. The GGAs are monomeric clathrin adapters composed of VHS, GAT, and 
GAE domains. GGAs are targeted to membranes through GAT domain binding to phospholipids and active Arf1. 
The VHS domain binds to cargo, while the GAE domain binds to accessory proteins. Clathrin binds GGAs at the 
hinge region along with the GAE domain to help form the clathrin coat. 
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main interaction interface for recruitment of endocytic accessory proteins to sites 
of vesicle formation (22–27). The β2-ear also serves in accessory protein 
recruitment during early steps of endocytic vesicle formation but then, together 
with clathrin box peptide motif in the β2-linker, becomes the major interface for 
clathrin recruitment and assembly at the forming vesicle (28). 
 
Endocytic accessory proteins 
As discussed above, productive endocytic vesicle formation depends on 
the coordinated formation of a complex protein machinery in which most 
components contribute to select aspects of vesicle formation. For example, the 
so-called alternate adapters β-arrestin, ARH, Dab2, AP180/CALM, epsin and 
HIP1/HIP1R, interact with cargo proteins as well as AP-2 and/or clathrin, thereby 
broadening the range of cargo molecules that can be enriched in the forming 
vesicle (29–33). Furthermore, in addition to AP-2, AP180/CALM also regulate 
clathrin polymerization during vesicle formation (22, 34). 
Most accessory proteins display a combination of signature peptide motifs 
and protein domains that link each component into the endocytic protein network 
and also determine their specific functions.  For example, phospho-tyrosine-
binding (PTB), AP180/epsin amino-terminal homology (ANTH/ENTH), and Bin-
amphiphysin-Rvs (BAR) domains target accessory proteins to the plasma 
membrane by binding to PI(4,5)P2 (10, 35). In addition, some of these lipid-
binding domains such as ENTH and Fes-CIP4 homology BAR (F-BAR) domains 
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also contribute to membrane deformation (10, 35). Numerous protein domains 
including Src homology 3 (SH3), PTB and pleckstrin homology (PH) domains 
form the protein-protein interactions that organize the endocytic protein 
machinery and drive vesicle formation and release forward (36–38). For 
example, it has been proposed that the SH3 domain-containing large GTPase 
dynamin, which severs CCVs off the membrane, functions as a major checkpoint 
that uses the spatiotemporal balance of accessory proteins as a signal for 
progression (12). 
 
Other clathrin-mediated transport pathways 
Besides its role in CME, clathrin also participates in sorting events at other 
cellular locations. For example, clathrin plays a more structural role on 
endosomes during the sorting of cargo into MVB for subsequent degradation. In 
addition, clathrin-coated vesicles/carriers form at the Golgi to transport cargo to 
endosomes and the cell surface. Similarly, clathrin-mediated sorting on 
endosomes sends cargo to the Golgi and the cell surface (Fig. 1.1). These 
intracellular transport pathways are regulated and often defined by specific 
members of the Rab and Arf families of small GTPases. Rabs and Arfs are 
activated by GTPase-specific guanine nucleotide exchange factors (GEFs) which 
remove GDP from an inactive GTPase to promote GTP loading, and inactivated 
by GTPase activating proteins (GAPs) which enhance GTP hydrolysis [5]. Upon 
activation, Rabs and Arfs recruit downstream effector proteins, including several 
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clathrin adapters that regulate individual aspects of the pathway ranging from 
cargo selection and sequestration to vesicle/carrier formation and transport along 
the cytoskeleton, and membrane fusion for cargo delivery [6]. 
The formation of clathrin-coated vesicles and carriers at intracellular 
organelles involves several clathrin adaptors, in particular the heterotetramic 
complexes AP-1 and AP-3 as well as the members of the Golgi-localized, 
gamma ear-containing, ARF-binding protein (GGA) family. AP-1 functions in both 
directions of vesicle/carrier transport between the Golgi and early and late 
endosomes (39). In addition, AP-1 has been linked to fast endocytic recycling 
(40). The trunk mediates AP-1 recruitment to the Golgi through interactions with 
cargo, PI(4)P and the active form of the small GTPase Arf1. Cargo and Arf1/Arf3 
also regulate AP-1 recruitment to endosomes; however, it remains unclear if 
PI(4)P or other phospholipids contribute as well. AP-1 binds to clathrin through its 
β1-adaptin subunit in a similar fashion to AP-2 (28). However, a key structural 
difference between AP-1 and AP-2 is that the ear domain of the AP-1 γ-adaptin 
subunit is smaller than the corresponding α-adaptin ear domain. Notably, the γ-
adaptin ear lacks a platform domain and thus misses the equivalent of a key 
binding site for accessory protein recruitment during CME. 
Eukaryotic cells also use three monomeric clathrin adapters called GGA 1-
3. Here, individual protein domains fulfill the same functions seen for the AP 
complexes, namely cargo, Arf1/3 and phospholipid binding as well as accessory 
protein and clathrin recruitment to the forming vesicle/carrier (41, 42). Each GGA 
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has been linked to both antero- and retrograde transport between the Golgi and 
endosomes (41, 43), yet, it remains unclear if the different family members serve 
in the sorting of common or distinct cargo. Furthermore, GGA1 and GGA3 have 
been found at endosomes with clathrin (41) and are linked to fast endocytic 
recycling, a transport pathway that routes cargo from early endosomes to the cell 
surface (44–46). 
Vesicle and carrier formation on internal membranes necessitates cargo 
selection, membrane deformation and vesicle/carrier release similar to the steps 
involved in CME. As a result, the protein machineries involved in each transport 
pathway are likely to show a similar complexity to the protein network driving the 
formation of CCVs at the plasma membrane. However, to date, we only have 
limited insights into the proteins and mechanisms that orchestrate cargo 
transport from internal organelles and in particular, from early endosomes. 
 
Endosomal recycling 
As mentioned above, EEs continuously receive newly synthesized 
transmembrane proteins from the Golgi as well as endocytic cargo from the cell 
surface. Cargo not destined for degradation are then sorted into a variety of 
transport pathway, including several pathways that send receptors and other 
proteins to the cell surface. In fact, the majority of internalized receptors undergo 
recycling back to the plasma membrane in order to replenish their cell surface 
pool (47) and maintain a wide range of complex cellular functions including 
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nutrient uptake, cell signaling, cell-cell adhesion, and cell migration (48–51). 
Consequently, misregulation of endosomal recycling directly contributes to wide-
spread human diseases such as cancer, diabetes and neurodegenerative 
disorders (6–9, 52).  
The individual recycling pathways are regulated by key GTPases that 
concentrate in early endosomal subdomains where they orchestrate the 
generation of cargo-containing tubules and carriers. For example, in the slow 
recycling pathway, cargo are sorted by Rab4b from EEs to Rab11a-positive 
recycling endosomes in the perinuclear region, from there Rab11a-labeled 
recycling carrier transport cargo to the cell surface (53, 54). For endocytic cargo 
such as TfnR and β1-integrin, the half-time (t1/2) for cycling from and to the cell 
surface along the slow recycling pathway is 10-30 minutes, depending on the cell 
line (55, 56).  
In addition, mammalian cells employ parallel fast recycling pathways 
organized by Rab4a, Rab35 and Arf6 that directly sort cargo from EEs to the 
plasma membrane with a fast kinetics of t1/2 equal to 2-5 minutes (56, 57). 
Importantly, the different pathways show some degree of cargo specificity. For 
example, the Rab35-mediated pathway controls the fast recycling of immune 
response receptors such as major histocompatibility complex (MHC) I and II (58, 
59), and T-cell receptor (60), as well as the recycling of the cell adhesion 
receptor E-cadherin to support cell-cell interactions (5). On the other hand, the 
Arf6-dependent fast recycling of β1-integrin regulates β1-integrin signaling at the 
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cell surface and downstream actin dynamics, thereby controlling cell migration 
(61–63) and cancer cell invasion (6, 64). In fact, there is direct cross-talk 
between the Rab35 and Arf6 pathways (5, 65). In addition to driving the recycling 
of their respective cargo, Rab35 and Arf6 each also recruit downstream effector 
proteins that decrease the activity of the other GTPase, thereby creating negative 
feedback loops that allow for cells to transition between cell-cell adhesion and 
cell migration (5). 
 
Rab4a-mediated fast recycling 
Rab4a was originally shown to work with AP-1 to control fast recycling (40, 
66). More recent studies revealed that Rab4a also controls AP-3- and GGA3-
mediated carrier formation on EEs (44). In fact, clathrin adapter recruitment 
downstream of Rab4a involves a multi-step GTPase cascade in which Rab4a 
activation results in the recruitment and activation of the small GTPase Arl1, 
leading to the recruitment of the Arl1 effector proteins BIG1 and BIG2 (44). 
BIG1/BIG2 function as GEFs for the activation of the small GTPases Arf1 and 
Arf3, which then serve as early endosomal docking sites for the recruitment of 
clathrin adapters downstream of Rab4a (44). In addition, Rab4a also recruits the 
retromer component Vps35 for retromer-mediated fast recycling from EEs to the 
cell surface (67). 
Several Rab4a effectors have been linked to the sorting of specific cargo, 
suggesting that different Rab4a effectors could control distinct, cargo-specific 
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sub-routes of the Rab4a fast recycling pathway. For example, Rab4a/AP-1, 
Rab4a/GGA3 and Rab4a/Vps35 drive the fast recycling of TfnR, Met receptor 
and β2-adrenergic receptor (β2AR), respectively (40, 45, 67). In contrast, 
Rab4a/AP-3-mediated sorting has been linked to the regulation of lysosome 
function (44, 68). Furthermore, Rab4a controls the sorting of a wide variety of 
additional cargo, including growth factor receptors such as EGFR and PDGFβ 
receptor as well as β3-integrin (69–71), and it has yet to be determined whether 
the different Rab4a effectors regulate overlapping or distinct sets of cargo and/or 
control the regulation of specific cell functions. However, addressing the role of 
individual Rab4a pathway sub-routes has thus far not been possible because 
manipulating the expression or function of the different clathrin adapters and 
Vps35 would also affect their role in transport to and from the Golgi. 
 
Endocytic recycling in cell migration and invasion 
Rab4a has a crucial role in cancer cell invasion and metastasis by 
controlling the recycling of a number of key migratory components to drive cell 
migration (69, 70, 72, 73). For example, Rac1 is activated on EEs by the GEF 
Tiam1 and then transported by Rab4a-dependent carriers to the leading edge, 
where Rac1 promotes lamellipodia formation and cell motility (74). Rab4a fast 
recycling also delivers signaling receptors such as PDGFβ-R and VEGFR to the 
leading edge to maintain pro-migratory signaling cascades (75, 76). Notably, 
cells increase Rab4a-mediated recycling in response to stimulation with growth 
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factors such as PDGF (70). Activation of receptor tyrosine kinases at the cell 
surface leads to the phosphorylation/activation of PKD1, which enables PKD1 to 
interact with β3-integrins present in EEs (77, 78). PKD1 then phosphorylates the 
Rab4a binding partner rabaptin-5 to drive Rab4a recycling carrier formation and 
β3-integrin recycling (78). Delivery of β3-integrins such as integrin αvβ3 to the 
leading edge allows cell to engage the extracellular matrix components 
fibronectin and vitronectin for persistent, directional migration and invasion (70, 
73, 79). In addition, signaling downstream of integrin αvβ3 results in localized 
activation of Rac1 and Rac1-driven actin polymerization dynamics and 
lamellipodia formation, further enhancing cell migration (80, 81).  
Rab11a also controls cell migration through the slow recycling of integrin 
α5β1, which binds to fibronectin (79, 82). Upon delivery to the cell surface, β1-
integrin also activates the RhoA/ROCK signaling pathway, leading to increased 
phosphorylation of the actin regulator cofilin, which inhibits the actin 
depolymerizing and severing activity of cofilin and allows for integrin α5β1-driven 
random cell migration (80, 81). Interestingly, there is cross-talk between the 
Rab4a- and Rab11a-dependent recycling pathways that allows for cells to switch 
between integrin αvβ3-dependent persistent directional and integrin α5β1-
dependent random cell migration. For example, growth factor-induced fast 
recycling of integrin αvβ3 leads to a concomitant downregulation of Rab11a-
mediated integrin α5β1 recycling and α5β1-dependent cell migration (70) (Fig. 
1.4). Reversely, depletion or mutation of Rab4a or PKD1 blocks integrin αvβ3-  
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Figure 1.4 - The Rab4a-mediated integrin switch. Growth factor stimulation of 
cells promotes the Rab4a-mediated fast recycling of integrin αvβ3. Integrin αvβ3 
promotes persistent migration through the activation of Rac1. Rapid recycling of 
integrin αvβ3 also negatively regulates the recycling of integrin α5β1 along the 
slow recycling pathway, leading to cells switching from integrin α5β1-mediated 
random cell migration to integrin αvβ3-mediated persistent cell migration. 
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mediated migration, which alleviates the inhibition of the slow Rab11a recycling 
pathway and allows for integrin α5β1-driven cell migration (73, 78).  
Notably, Rab4a and β3-integrin expression is amplified in several cancers, 
including 25% of breast cancers, highlighting the role of Rab4a-mediated fast 
recycling of β3-integrin in cancer cell invasion and metastasis (73). However, our 
limited insights into the protein machineries that control Rab4a-mediated fast 
recycling and the additional roles of the Rab4a effector proteins in Golgi transport 
have thus far limited the options to selectively target select Rab4a sub-routes 
and cargo, in particular to interfere with Rab4a-driven cancer cell invasion and 
metastasis. 
 
Adaptin-ear-binding coat-associated proteins (NECAPs) 
The two members of the adaptin-ear-binding coat-associated protein 
(NECAP) family, NECAP1 and NECAP2, were originally identified in a subcellular 
proteomics analysis of CCVs isolated from adult rat brain (83). NECAP1 
expression is highest in the brain, with lower levels expressed in other tissues 
and cell lines (83, 84). NECAP2 is ubiquitously expressed, with higher levels in 
several human tissues including breast and adipose tissue (85).  
NECAP1 and NECAP2 share 62% sequence identity and are 
evolutionarily conserved (Fig. 1.5), however, they lack sequence homology to 
other proteins (37). At their N-terminus, NECAPs contain a highly conserved 
region that encodes a PH domain, which functions as a protein binding module, 
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Figure 1.5 - NECAP sequence alignment. Protein sequence alignment of murine NECAP1 and NECAP2 with 
Drosophilia NECAP, the only family member expressed in fly. The N-terminal region is highly conserved (green) 
through evolution and between NECAP1 and NECAP2. The C-terminal regions show a higher degree of variability 
but containsthe highly conserved WxxF peptide motifs for binding to AP-1 (blue) and AP-2 (red). 
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as well as an extended unstructured region. The C-terminal region shows the 
highest degree of sequence variation between the NECAP family members but 
contains two highly conserved peptide binding motifs for interactions with AP-1 
and AP-2 (Fig. 1.5). Specifically, the WxxF-acidic motif at the very C-terminus 
binds to the sandwich subdomain of the AP-2 α-ear, while a second WxxF-based 
motif 17 amino acids upstream of the α-ear-binding motif selectively binds to the 
γ-ear of AP-1 and the corresponding γ-adaptin ear (GAE) domain of GGAs (86, 
87). 
The NECAP PH domain interacts with endocytic accessory proteins by 
binding to a FxDxF peptide motif, which initially were identified as peptide motifs 
for interactions with the platform sub-domain of the AP-2 α-ear (37, 88). 
Interestingly, the NECAP PH domain and AP-2 α-ear share no sequence or 
structural similarity, yet evolved to engage the same peptide motif (37). In vitro 
binding studies showed a large overlap in PH domain binding partners for 
NECAP1 and NECAP2 even though NECAP1 in general shows stronger binding 
(37). Functional studies demonstrated that NECAP1 cooperates with AP-2 to 
control the formation of endocytic CCVs at the plasma membrane (84). Through 
its C-terminal WxxF-acidic motif, NECAP1 binds to the α-ear sandwich sub-
domain such that the PH domain and the α-ear platform domain are able to 
cooperate in the recruitment of FxDxF motif-containing accessory proteins to the 
forming vesicle (84, 86). Knock-down of NECAP1 impairs the recruitment of 
accessory proteins such as CALM and FCHo1/2 to the forming vesicles and  
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Figure 1.6 - Model of NECAP1 binding to AP-2. The NECAP1 PH domain 
forms two types of interactions: 1) The PH domain, together with extended 
conserved region, binds to the β2-linker and blocks the clathrin binding site. This 
limits access of clathrin to AP-2 and blocks accessory protein binding to the 
NECAP1 PH domain, suggesting the NECAP1/AP-2 complex is in a closed, 
inactive conformation (left). 2) During vesicle formation (right), clathrin competes 
NECAP1 off the β2-linker, allowing for the β2-ear and β2-linker to polymerize the 
clathrin coat and for the α-ear and the NECAP1 PH domain to cooperate in 
accessory protein recruitment.  
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alters vesicle number, size and cargo content, highlighting that the 
spatiotemporal control of accessory protein recruitment is critical for normal 
vesicle formation (84). 
The NECAP1 PH domain also interacts with the AP-2 β2-linker despite the 
lack of FxDxF peptide motifs in the β2-linker sequence. Notably, β2-linker binding 
strongly increases when the PH domains functions in conjunction with the 
extended unstructured region, suggesting the conserved N-terminal region of 
NECAP1 as a whole functions as AP-2-binding module (84). Furthermore, the 
binding site for NECAP1 in the β2-linker overlaps with the binding site for the 
clathrin terminal domain and in fact, NECAP1 and clathrin compete with each 
other for access. These interactions suggest a model in which NECAP1 uses the 
WxxF-acidic motif to interact with the α-ear while the conserved N-terminus binds 
to the β2-linker, leading to a closed-conformation complex that limits access of 
clathrin to AP-2, likely prior to vesicle formation (Fig. 1.6). Upon recruitment to 
vesicle formation sites, clathrin terminal domain binding to the β2-linker would 
then open the NECAP1/AP-2 complex and allow for the PH domain and α-ear to 
cooperatively control accessory protein recruitment while the β2-linker and -ear 
drive the polymerization of the clathrin coat during CME (Fig. 1.6) (84). 
 
NECAP2 and research goals 
Despite the high degree of structural and sequence similarity between the 
NECAP family members and the overlap in protein binding partners in vitro, 
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NECAP2 fails to rescue the endocytic defects caused by NECAP1 KD, 
suggesting that NECAP2 may not function with AP-2 in CME. However, the 
precise role of NECAP2 in protein transport and the identity of the transport 
pathway(s) involved are yet to be defined. Similar to the insights into the 
molecular mechanisms controlling CME gained from the analysis of NECAP1, 
the functional characterization of NECAP2 has the potential to provide new 
insights into the regulation of ill-defined protein transport pathways and their role 
in the dynamic control of cell function and behavior. Thus, the objectives of this 
thesis research are to:  
1) Identify which intracellular transport pathway(s) dependent on NECAP2 
function,  
2) Determine the role of NECAP2 in intracellular transport, and 
3) Define the role of NECAP2-dependent transport in normal cell physiology 
and disease.  
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 CHAPTER II – MATERIALS AND METHODS 
Cell culture 
MCF10A (human breast epithelial), HeLa (human cervix epithelial), HEK-
293T (human kidney epithelial), NIH3T3 (mouse embryo fibroblast), and COS-7 
(monkey kidney fibroblast) cells were obtained from ATCC (Manassas, Virginia). 
MDA-MB-231 (human breast cancer) cells Dr. Varelas and LM2 (human breast 
cancer) cells were a generous gift from Dr. Kathrin Kirsch (Boston University). 
MCF10A cells were cultured in DMEM/F12 (1:1) (11330-032, Thermo Scientific, 
Waltham, MA) supplemented with 5% horse serum (HS) (16050-122, Thermo 
Scientific), 20 ng/mL epithelial growth factor (EGF) (AF-100-15, PeproTech, 
Rocky Hill, NJ), 500 ng/mL hydrocortisone (4-0888, Sigma-Aldrich, St. Louis, 
MO), 100 ng/mL cholera toxin (C-8052, Sigma-Aldrich), and 10 μg/mL insulin (I-
1882, Sigma-Aldrich) as described by Debnath et al. (89), with the omission of 
Pen/Strep in all solutions. HeLa, COS-7, HEK 293-T, NIH3T3, MDA-MB-231, and 
LM2 cells were cultured in DMEM High Glucose (SH30243, Hyclone 
Laboratories, Logan, UT) supplemented with 10% iron-supplemented calf serum 
(SH30072.03, Hyclone) in a 37ºC, 5% CO2-containing, water-saturated 
atmosphere.  
For transient protein expression, HEK 293-T cells were transfected using 
calcium phosphate (90). In short, for transfection of a T175 flask containing 1.2-
1.5 × 107 cells in 25 mL medium, 1.875 ml of 2x HBS (280 mM NaCl, 1.5 mM 
Na2HPO4, 50 mM HEPES, pH 6.98-7.04 depending on efficiency) was mixed with 
 25 
9.9 ml TE 0.1x (1mM Tris base, 0.1 mM EDTA, pH 8.0) containing 0.225 ml of 2 
M CaCl2 and DNA for the packaging mix and miRNA vector. The resulting 
solution was incubated 20 minutes at room temperature before being added to 
fresh media on HEK-293T cells in fresh culture media. MCF10A, COS-7, and 
HeLa cells were transfected using jetPrime (Polyplus Transfection, New York, 
NY) according to the manufacturer’s recommendations. Five hours after addition 
of the transfection mix to the cells, the medium was removed and replaced with 
regular culture medium.  
 
Virus production and protein knock-down 
Control and NECAP2 KD viruses were generated and produced as 
previously described (84, 90). In short, HEK-293T cells were co-transfected with 
25 µg of pMDLg/pRRE, 15 µg of pMD2.g, 12.5 µg of pRSV-REV, and 50 µg of 
expression plasmid. Media was replaced with fresh culture media after 8 hours 
to. Media were collected 24, 36, and 48 hours post transfection, filtered through 
0.45 μm polyethersulfone membrane filters (09-740-63B, Thermo Scientific) to 
remove cell debris and concentrated by centrifugation at 17,000 xg overnight 
before resuspension in 1:2000 original volume with DMEM. The two human 
NECAP2 target sequences start at nucleotide 341 (KD1) and 388 (KD2) of the 
human NECAP2 open reading frame (accession number NM_018090) and the 
mouse NECAP2 target sequences start at nucleotide 258 (KD1) and 649 (KD2) 
of the mouse NECAP2 open reading frame (accession number NM_025383). 
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The NECAP1 KD constructs target sequences started at nucleotide 162 (KD1) 
and 220 (KD2) of the human NECAP1 open reading frame (accessrion number  
NM_015509) and were described previously (84). The two Rab4a target 
sequences start at nucleotide 335 (KD1) and 554 (KD2) of the human Rab4a 
open reading frame (accession number NM_004578). For protein KD, cells were 
plated late in the day before transduction. Within 16 hours after plating, the 
culture medium was replaced by regular culture medium supplemented with 6 
µg/ml polybrene (SIGMA-Aldrich), and viruses were added at a multiplicity of 
infection (MOI) of 5. After 5 hours, media was replaced with fresh culture medium 
and the cells were maintained until assays were performed 2 - 6 days after 
transduction. 
 
Western blots 
Cells were lysed with ice-cold lysis buffer (10 mM HEPES, pH 7.4, 150 
mM NaCl, 2 mM EGTA, 2 mM EDTA, 25 mM sodium pyrophosphate, 50 mM β-
glycerophosphate, 1% Triton X-100, 50 mM sodium fluoride, 1 mM sodium ortho 
vanadate, 0.83 mM benzamidine, 0.23 mM PMSF, 0.5 µg/ml aprotinin, 0.5 µg/ml 
leupeptin) and centrifuged for 20 min at 21,000 xg to remove cell fragments. 
Protein concentration of the resulting supernatant was determined by Bradford 
protein assay. Reducing sample loading buffer (30% SDS, 2M Sucrose, 2M Tris-
Cl pH 6.8, 5% β-mercaptoethanol, bromophenol blue) was added to equal protein 
amounts and samples were boiled at 95°C for 5 minutes. Samples were loaded 
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and separated on freshly made 5 – 16% or 7 – 18% gradient SDS-PAGE gels 
(Stacking gel: 3.5% acrylamide, 0.5 M Tris-Cl (pH 6.8), 0.4% SDS, 0.6% APS, 
0.07% TEMED; Resolving gel: 5 - 18% acrylamide, 1.5 M Tris-Cl (pH 8.7), 0.4% 
SDS, 0.4% APS, 0.04% TEMED) in SDS-PAGE running buffer (25 mM Tris, 192 
mM glycine, 0.1% SDS) at 295 V for 2 hours and 30 minutes. Proteins were 
transferred onto 0.22 μm nitrocellulose membranes (1212632, GVS Filter 
Technology, Sanford, ME) by transferring in 1X transfer buffer (25 mM Tris, 195 
mM glycine, 9% methanol) at 25 V for overnight. Membranes were stained with 
Ponceau S at room temperature and washed with water until protein bands were 
visible to confirm uniform protein transfer. Images were captured to visualize total 
protein.  Membranes were then blocked for 1 hour at room temperature in either 
5% nonfat dry milk (Nestle Baking, Solon, OH) in Blotto (60 mM NaH2PO4, 150 
mM NaCL, pH 8.0) or 5% BSA (BP1600-100, Fisher Scientific) diluted in TBS-T 
(20 mM Tris pH 7.4, 150 mM NaCl, 0.1% Tween-20). Membranes were 
incubated in primary antibody diluted in blocking solution overnight at 4°C. The 
following day, membranes were washed 3 times for 10 minutes each in TBS. 
Membranes were then incubated in secondary antibody conjugate to HRP diluted 
in blocking solution, for 1 hour at room temperature, followed by 3 washes for 10 
minutes each in TBS.  Antibody signal was immediately visualized by exposure 
to Western Lightning ® Plus-ECL (NEL104001EA, Perkin Elmer, Waltham, MA) 
or Western Lightning ® ECL Pro (NEL121001EA, Perkin Elmer), and imaged on 
a Chemi Doc™ XRS+ imaging
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Table 2 – Antibodies 
 
Specificity Host Source Catalog No. Application (Concentration)
adadptin α mouse BD Bioscience 610502 IF (1:100)
adaptin γ (clone 88) mouse BD Bioscience 610386 IF (1:100), WB (1:1000)
clathrin heavy chain (clone 23) mouse BD Bioscience 610500 WB (1:1000)
EEA1 (clone 14) mouse BD Bioscience 610457 IF (1:500), WB (1:10000)
EGFR mouse Santa Cruz Biotechnology sc-120 IF (1:100), recycling (1:100)
EGFR rabbit Santa Cruz Biotechnology sc-03 WB (1:500)
TfnR (CD71) mouse Santa Cruz Biotechnology sc-65882 IF (1:200), WB (1:500)
EEA1 rabbit Cell Signaling Technologies 2411S IF (1:50)
TGN46 rabbit Abcam ab50595 IF (1:500)
Rab11 rabbit Thermo Scientific 71-5300 IF (1:100)
NECAP2 rabbit Ritter et al., 2003 WB (1:2000)
NECAP2 rabbit Sigma-Aldrich HPA028077 IF (1:250)
Flag (M2) mouse Sigma-Aldrich F1804 IF (1:50000), WB (1:20000)
NECAP1 rabbit Ritter et al., 2003 WB (1:5000)
Vps35 goat Abcam ab10099 IF (1:100)
c-myc rabbit Sigma-Aldrich C3956 IF (1:1000)
AP-3 (delta subunit) mouse Hybridoma Bank anti-delta SA4-c IF (1:100)
β1 integrin rabbit Cell Signaling Technologies 4706 ELISA (5ug/ml)
β3 integrin mouse BD Bioscience 555752 ELISA (5ug/ml)
anti-mouse 555 Alexa Fluor goat Molecular Probes A21424 IF (1:500)
anti-rabbit 555 Alexa Fluor goat Molecular Probes A21429 IF (1:500)
anti-mouse 647 Alexa Fluor goat Molecular Probes A21236 IF (1:500)
anti-rabbit 647 Alexa Fluor goat Molecular Probes A21245 IF (1:500)  
 
Table 1 - Antibodies. List of antibodies used for western blot and immunofluorescence analysis. Antibodies for 
western blot analysis were used following manufacturer’s instructions for blocking reagent. NECAP1 and NECAP2 
antibodies produced in-house were blocked and incubated in 5% nonfat dry milk in Blotto.   
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station (Bio-Rad Laboratories, Hercules, CA) using Image Lab software (Bio-Rad 
Laboratories). Proteins were compared to 1:1 mixture of Low Range (161-0304, 
Bio-Rad Laboratories) and High Range (161-0303, Bio-Rad Laboratories) SDS-
PAGE molecular weight standards to determine size. Antibodies used are listed 
in Table 1. 
 
Immunofluorescence analysis 
For protein localization studies, cells were plated on 12 mm poly-L-lysine 
(PLL)-coated coverslips, no 1.5 (NeuVitro Corporation, Vancouver, WA). The day 
of immunostaining, cells were washed with PBS, fixed with 2% paraformaldehyde 
in PBS for 10 min at RT, and permeabilized with 0.2% Triton X-100 in PBS for all 
antibodies but Rab11a. Antibodies were diluted with 0.02% Triton X-100 in PBS 
and incubated at RT. For cell surface staining, cells were processed as described 
above but omitting the cell permeabilization step and diluting antibodies in PBS 
alone. For detection of Rab11a, after fixation, cells were incubated with primary 
and secondary antibodies diluted in PBS + 0.05% saponin. Secondary antibodies 
were conjugated with Alexa555 or Alexa647 and samples were mounted using 
Prolong Diamond antifade reagent (Thermo Scientific). 
 
Fluorescence imaging 
Images were collected on a Zeiss Observer D1 equipped with Colibri.2 
and HXP light sources and an ORCA-Flash 4.0 digital CMOS camera 
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(Hamamatsu, Bridgewater, NJ). For some experiments, as indicated in the figure 
legend, images were collected on a Zeiss LSM 700 confocal microscope. For all 
quantitative analyses, image acquisition settings were set such that signals were 
not saturated for the brightest samples according to the range indicator feature in 
the ZEN imaging software (ZEISS, Germany) and settings were kept constant for 
all images. 
 
EGFR internalization 
Cells were plated in replicates two days before the experiment, starved 
overnight in serum-free medium and incubated with 2 ng/ml EGF-Alexa647 
(Thermo Scientific) in cold serum-free medium on ice for 1 hour. One set 
(surface) was washed with PBS, fixed with ice-cold 2% paraformaldehyde in PBS 
for 20 min on ice, washed again and mounted. The second set was incubated 
with pre-warmed serum-free medium for 2.5 min at 37ºC, acid washed (0.2 M 
acetic acid, 0.5 M NaCl) on ice to remove residual EGF from the cell surface, and 
then processed as described in immunofluorescence analysis. 
 
EGFR recycling  
For EGFR recycling following TGFα treatment, cells were plated in four 
replicates one to two days before the experiment and starved in serum-free 
medium for 1 hour. The first set of cells was immediately placed on ice and 
processed as described below. The other three sets of cells were incubated with 
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pre-warmed serum-free medium containing 10 nM TGFα (100-16A, PeproTech) 
for 4 minutes at 37ºC to allow for EGFR internalization, then acid washed on ice. 
Two sets of cells were returned to 37ºC in pre-warmed serum-free medium for 3 
and 5 minutes to allow for receptor recycling, then acid washed on ice. All 
samples were incubated for 45 minutes with an antibody directed against the 
extracellular region of EGFR (sc-120, Santa Cruz Biotechnology) diluted 1:100 in 
regular culture medium to label the surface pool of EGFR. Cells were washed 
and lysed in RIPA buffer (20 mM Tris pH 7.4, 150 mM NaCl, 1mM EDTA, 1% 
NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 1% Triton X-100) supplemented 
with 0.83 mM benzamidine, 0.23 mM PMSF, 0.5 µg/ml aprotinin, 0.5 µg/ml 
leupeptin. Lysates were cleared by centrifugation at 200,000 xg for 20 minutes at 
4ºC and aliquots of 100 µg of total protein were incubated with sheep anti-mouse 
IgG Dynabeads (11201D, Thermo Scientific) for 1 hour on an orbital shaker at 4º 
C. After three washes with RIPA buffer, bound proteins were resolved by SDS-
PAGE and EGFR levels were detected by Western blot. 
 
EGFR degradation  
Cells were plated in replicates for each time point one to two days before 
the assay. On the day of the experiment, cells were stimulated with 1.5 or 50 
ng/ml EGF in pre-warmed regular culture medium for varying lengths of time at 
37ºC, shifted onto ice, washed with ice-cold PBS and lysed with ice-cold lysis 
buffer (10 mM HEPES, pH 7.4, 150 mM NaCl, 2 mM EGTA, 2 mM EDTA, 25 mM 
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sodium pyrophosphate, 50 mM β-glycerophosphate, 1% Triton X-100, 50 mM 
sodium fluoride, 1 mM sodium ortho vanadate, 0.83 mM benzamidine, 0.23 mM 
PMSF, 0.5 µg/ml aprotinin, 0.5 µg/ml leupeptin). Cells were scraped and 
disrupted by mechanical force. After centrifugation for 20 min at 21,000 xg, 
supernatants were collected, resolved by SDS-PAGE and total EGFR levels 
were detected by Western blot. 
 
Transferrin internalization  
For analysis by fluorescence imaging, cells were plated in replicates for 
each time point one to two days before the assay. On the day of the experiment, 
cells were fed with 13 µg/ml human transferrin-Cy3 (Jackson ImmunoResearch, 
West Grove, PA) in pre-warmed regular culture medium for varying lengths of 
time at 37ºC. For each time point, cells were shifted onto ice and the surface pool 
of transferrin-Cy3 was stripped off by acid wash. Cells were then washed with 
ice-cold PBS, fixed with ice-cold 2% paraformaldehyde in PBS for 20 min on ice, 
washed again and mounted for analysis by fluorescence microscopy. For 
analysis by quantitative infrared fluorescence measurement, four sets of cells 
were incubated with pre-warmed serum-free media for 2 hours at 37°C. One set 
was immediately placed on ice and washed and lysed as described below. The 
other three sets of cells were incubated with 13ug/ml transferrin-Alexa647 
(Thermo Scientific) in serum-free media on ice for 30 minutes to label the surface 
pool of TfnR. Two cell sets were then incubated with pre-warmed serum-free 
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media at 37°C for 1 or 4 minutes to allow for internalization, followed by an acid 
wash on ice. All sets of cells were washed 2-3 times with cold PBS on ice, lysed 
in RIPA buffer supplemented with 0.83 mM benzamidine, 0.23 mM PMSF, 0.5 
µg/ml aprotinin, 0.5 µg/ml leupeptin and equal amounts of total protein extract 
were separated by SDS-PAGE. The level of transferrin-Alexa647 in each extract 
was quantified by infrared fluorescence measurement using an Odyssey 
imagining system (LI-COR Biosciences, Lincoln, NE) and clathrin heavy chain 
(CHC) levels were detected by Western blot. 
Transferrin recycling  
For transferrin recycling assays, cells were fed with 13 μg/ml human 
transferrin-Cy3 in regular medium for various lengths of time at 37ºC. The cells 
were then placed on ice and surface-bound transferrin was removed by acid 
wash, followed by a PBS wash. The 0 min time point samples were fixed with 2% 
paraformaldehyde in PBS for 20 min on ice, washed and mounted. The samples 
for later time points were shifted to 37ºC and incubated with pre-warmed regular 
medium. For each time point, samples were placed on ice, washed with PBS and 
processed as described for the 0 min samples. 
 
Rescue studies  
Control and NECAP2 KD cells were plated in replicates two to three days 
before the assay and transduced at a MOI of 2 following the transduction 
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protocol described for protein KD the day before the assay with RFP-Flag- 
tagged: 
• wildtype NECAP2,  
• wildtype NECAP1,  
• the NECAP2 PH mutant (containing an alanine substitution at arginine-
101; R101A), 
• the NECAP2 AP-1 mutant (containing a double alanine substitution at 
tryptophan-243 and phenylalanine-246; W243A/F246A),  
• the NECAP chimera consisting of NECAP2 PH domain (aa 1 - 132), 
NECAP2 extended conserved region (aa 132 - 177), NECAP1 C-terminus 
(aa 179 - 275),  
• the chimera of NECAP2 PH domain,  NECAP1 extended conserved 
region (aa 134 - 178), NECAP2 C-terminus (aa 178 - 266), or  
• the chimera of NECAP1 PH domain (aa 1 – 133), NECAP2 extended 
conserved region, and NECAP2 C-terminus,  
The intracellular localization of endogenous AP-1 was determined by 
immunofluorescence imaging using Alexa647 conjugated secondary antibodies. 
 
Immunoprecipitation  
HEK-293T cells were plated at 3.5x106 cells per 10 cm dish one day 
before transfection and transfected with 5 µg of DNA/dish for the various NECAP 
expression constructs. The following day, cells were lysed in 10mM HEPES, pH 
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7.4, 50mM NaCl, 1% Triton, 0.83 mM benzamidine, 0.23 mM PMSF, 0.5 µg/ml 
aprotinin, and 0.5 µg/ml leupeptin. Lysates were cleared by centrifugation at 
200,000 xg for 20 minutes at 4ºC, followed by pre-clearing with protein G 
agarose beads (Thermo Scientific). Flag-tagged NECAP proteins were isolated 
by immunoprecipitation using the Flag M2 antibody (SIGMA Aldrich), and bound 
proteins were resolved by SDS-PAGE and detected by Western blot.  
For binding partner identification, HEK-293T cells were plated at 12x106 cells per 
15 cm dish one day before transfection with 25 µg of either Flag-tagged full 
length NECAP1 or NECAP2 and underwent immunoprecipitation as described 
above. Flag-tagged NECAP conjugated beads were then incubated in 4 mg/ml 
additional protein extracts from wild-type HEK-293T cells, before being washed 3 
times with lysis buffer and resolved by SDS-PAGE. The gel was stained with 
Coomassie and lanes were excised for protein identification by mass 
spectrometry in collaboration with Dr. Cathy Costello (Boston University School 
of Medicine). 
  
Surface biotinylation 
MDA-MB-231 cells were serum starved overnight before treatment with 
20ng/ml PDGF-BB (Peprotech, #100-14B) for 30 minutes at 37ºC. Cells were 
then transferred to ice, washed twice in cold PBS, and surface-labelled on ice 
with 0.25 mg/ml EZ-Link Sulfo-NHS-SS-Biotin (PI21331, Thermo Fisher) in PBS 
containing 2 mM MgCl2 for 10 minutes. Labelled cells were then quenched with 
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100 mM glycine in DMEM containing 2 mM MgCl2 for 10 minutes on ice. Cells 
were rinsed once with cold HBS++ (10 mM HEPES pH 7.4, 150 mM NaCl, 0.7 
mM CaCl2, 0.5 mM MgCl2) before being washed twice with cold PBS. Cells were 
then scrapped in lysis buffer containing 75 mM Tris pH 7.5, 200 mM NaCl, 7.5 
mM EDTA, 7.5 mM EGTA, 1.5% Triton, 0.75% nonidet P40, 0.83 mM 
benzamidine, 0.23 mM PMSF, 0.5 µg/ml aprotinin, and 5 µg/ml leupeptin. 
Lysates were passed 10 times through a ball bearing cell cracker and spun at 
21,000 xg for 15 minutes. Supernatants were collected and biotinylated integrins 
were analyzed by capture-ELISA. 
 
Integrin capture-ELISA 
Integrin capture-ELISA assays were set up as previously described by 
Roberts et al. (70). 96-well Nunc Maxisorp plates (Invitrogen) were coated 
overnight with 5 µg/ml of anti-β1 integrin or anti-β3 integrin antibodies in 0.05 
Na2CO3 (pH 9.6) at 4°C. The plates were then blocked with PBS containing 
0.05% Tween-20 (PBS-T) and 5% BSA for 1 hour at room temperature. Equal 
protein concentrations of cell lysates were then incubated overnight at 4°C. The 
plates were then washed three times with PBS-T for 10 minutes each before 
incubation with streptavidin-horseradish peroxidase (GE Healthcare, #RPN1231) 
in PBS-T containing 1% BSA for 1 hour at 4°C. After three additional washes, 
integrin levels were detected by incubation with 0.5 mg/ml ortho-
phenylenediamine in 0.05 M citric acid, 0.05 M sodium phosphate, and 0.03% 
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hydrogen peroxide, pH 5.0, before the reaction was stopped with 2 M sulfuric 
acid and absorbance was measured at 490 nm. 
 
Rac1 pull-down assay  
Approximately 15-20 million cells were lysed on ice in 1 ml of 2.5 mM 
HEPES pH 7.4, 150 mM NaCl, 10 mM MgCl2, 1 mM EDTA, 1% NP-40, 2% 
glycerol, 0.83 mM benzamidine, 0.23 mM PMSF, 0.5 µg/ml aprotinin, and 0.5 
µg/ml leupeptin.  Lysates were sonicated on ice for 5-8 seconds at 30% output 
intensity (Branson Sonifier 450; VWR International, Radnor, PA) and then 
centrifuged at 16,200 xg in a microfuge (Sorvall Legend Micro 21; Thermo 
scientific) for 15 minutes at 4°C. Cell lysates were brought to 4 mg/ml protein 
concentration and 1 ml aliquots were incubated for 1 hr at 4ºC with 60 µg GST-
PAK-CRIB, or GST alone, pre-coupled to glutathione-sepharose. Samples were 
resolved on a 7-18% SDS-PAGE gel at 50 volts overnight and Rac1 levels were 
determined by Western blot. 
 
Cell proliferation assay 
Cell proliferation was determined by the fraction of cells incorporating 
Bromo-2'-deoxy-uridine (BrdU) within 60 min. The assay was performed using 
the BrdU Labeling and Detection Kit I (Roche Diagnostics Corporation, 
Indianapolis, IN) according to the manufacturer’s instructions. 
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Cell size measurements 
 Cells were trypsinized and resuspended in PBS. Cell solutions were 
mounted on a slide and transmitted light images were taken using a 10X 
objective. Cell diameter was measured using ImageJ (91). 
 
Cell migration assays 
For MCF10A scratch wound assays, cells were grown to confluency and 
wounded by scratching a 200 µl pipet tip across the culture dish well. Loose cells 
were removed by vigorous washing with regular culture medium. Cells were 
placed into fresh regular culture medium and incubated at 37ºC. Images were 
taken immediately after scratching (0hr) and 11 hr after wounding when control 
cells were about to close the wound. Migration of NECAP2 KD cells was 
quantified as fraction of the distance migrated by control cells. To label the actin 
cytoskeleton with phalloidin-Alexa647, cells were grown to confluency on PLL-
coated coverslips, wounded as described above and processed for imaging 6 hr 
after wounding. 
For MDA-MB-231 live cell scratch wound assay, a 12-well plate was 
coated with 10 µg/ml human fibronectin (J64738, Alfa Aesar, Tewksbury, MA) in 
PBS or 10 µg/ml vitronectin (07180, STEMCELL Technologies, Vancouver, BC) 
in PBS for 3 hours. Cells were plated on coated wells and allowed to grow to 
confluency. Cells were then serum-starved overnight, scratch wounded, washed 
and treated with 20 ng/ml PDGF-BB in DMEM before right before being imaged 
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at 37°C, 5% CO2 every 10 minutes for 5 hours. Individual cells were tracked in 
ImageJ as described in quantification and statistics. 
 
Three-dimensional invasion assay 
To define the role of NECAP2 in integrin αvβ3- and integrin α5β1-
mediated invasion, control, NECAP2 KD, and Rab4a KD LM2 cells were 
trypsinized and seeded as single cells into 3D gels formed with growth-factor 
reduced matrigel (354230, Corning, Corning, NY). Eight-well glass-bottom 
chamberslides were coated with a thin layer of 2% agarose in HBSS (SH30588, 
GE Healthcare Life Sciences) to prevent cells from attaching to the glass and 
5,000 single cells per conditions were mixed into gels containing 40% matrigel in 
serum-containing medium before gels solidified. In some cases, gels were 
supplemented with fibronectin (10 μg/ml, 07159, STEMCELL Technologies) to 
promote α5β1-driven invasion. Once gels had set, 500 μl of regular growth 
medium was added to each well and transmitted light images were collected nine 
days after plating using a 5x objective for increased focal depth. Invasion was 
quantified by binning structures by shape/organization: highly invasive (colonies 
that spread far into the gel), invasive (colonies with limited invasion into the gel, 
sometimes containing a denser cell cluster), or spherical (round-shaped colonies 
with little or no cell extentions into the gel). 
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Quantification and statistics  
Western blots and fluorescence images were quantified using ImageJ 
(91). For fluorescence analysis of cells, signal intensities were measured as 
integrated densities and size was measured by signal area. Colocalization of two 
markers was quantified using the Colocalization PlugIn for ImageJ. The PlugIn 
allows to determine the fraction of signal area of one marker that 
overlaps/colocalization with the area occupied by a second marker. The resulting 
mask is then redirected to the individual channels of the original image to 
determine the signal intensity within the colocalizied area. After determining total 
signal intensity of the marker, one can calculate the colocalized fraction of signal 
intensity. Cell migration was tracked by the manual tracking PlugIn for ImageJ. 
The PlugIn plots the track of individual cells that have been manually recorded 
over each frame. The velocity, distance, and graphs were reported by the 
chemotaxis tool PlugIn (IBIDI GmbH, Planegg, Germany). The PlugIn calculates 
each value and plots graphs based upon the reports generated in the manual 
tracking PlugIn. GraphPad Prism 5 was used for statistical analysis, details about 
data analysis and post-tests are included in the figure legends where 
appropriate. 
 
.
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 CHAPTER III - NECAP2 CONTROLS CLATHRIN COAT RECRUITMENT 
TO EARLY ENDOSOMES FOR FAST ENDOCYTIC RECYCLING 
Disclaimer: This chapter is adapted from Chamberland, J. P., Antonow, L. T., 
Dias Santos, M., and Ritter B. (2016) NECAP2 controls clathrin coat recruitment 
to early endosomes for fast endocytic recycling. Journal of Cell Science 129(13), 
2625-37. 
 
Abstract 
Endocytic recycling returns receptors to the plasma membrane following 
internalization and is essential to maintain receptor levels on the cell surface, 
resensitize cells to extracellular ligands and for continued nutrient uptake. Yet, 
the protein machineries and mechanisms driving endocytic recycling remain ill-
defined. Here, we establish that NECAP2 regulates the endocytic recycling of 
EGFR and transferrin receptor. Our analysis of the recycling dynamics revealed 
that NECAP2 functions in the fast recycling pathway that directly returns cargo 
from early endosomes to the cell surface. In contrast, NECAP2 does not regulate 
the clathrin-mediated endocytosis of these cargo, the degradation of EGFR, or 
the recycling of transferrin along the slow, Rab11-dependent recycling pathway. 
We show that protein knock-down of NECAP2 leads to enlarged early 
endosomes and causes the loss of the clathrin adapter AP-1 from the organelle. 
Through structure-function analysis, we define the protein binding interfaces in 
NECAP2 that are critical for AP-1 recruitment to early endosomes. Together, our 
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data identify NECAP2 as a pathway-specific regulator of clathrin coat formation 
on early endosomes for fast endocytic recycling.  
 
Introduction 
Receptor levels at the cell surface are dynamically regulated to control 
numerous cellular functions including receptor signaling, nutrient uptake and cell 
migration. To remove membrane-bound molecules and receptor/ligand 
complexes from the surface, these cargo are internalized through clathrin-
mediated and clathrin-independent endocytosis. Internalized receptors then enter 
early endosomes, which function as the key sorting station deciding the fate of 
receptor cargo. Ubiquitinated receptors engage the ESCRT complex for sorting 
into multivesicular bodies and subsequent receptor degradation (92). The 
degradative pathway is critical for the termination of signaling cascades 
downstream of ligand-activated receptor tyrosine kinases such as epidermal 
growth factor receptor (EGFR). In contrast, endocytic recycling returns receptors 
to the cell surface, thereby replenishing the surface pool of receptors to 
resensitize cells to extracellular ligands, maintain nutrient supply, and promote 
cell motility (48, 93, 94). Early endosomal sorting and endocytic recycling are 
regulated by members of the Arf and Rab families of small GTPases. Activation 
of Rabs and Arfs by guanine-nucleotide exchange factors (GEFs) enables the 
GTP-bound GTPases to recruit downstream effector proteins that fulfill pathway-
specific functions and promote the formation of cargo-carrying vesicles and 
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tubules. For example, Rab35 mediates cadherin recycling while Arf6 controls β1-
integrin recycling (5). Transferrin receptor (TfnR) is the canonical marker of 
endocytic recycling and transferrin remains bound to the receptor until TfnR 
reaches the cell surface. Notably, TfnR enters into recycling pathways with 
differential kinetics (95). The fast recycling pathway directly returns TfnR from 
early endosomes to the cell surface and is regulated by Rab4a (96). In the slow 
recycling pathway, Rab4b-mediated sorting sends TfnR from early to Rab11a-
positive recycling endosomes for subsequent transport to the cell surface (51–
53).  
The fast and slow recycling pathway both recruit the clathrin adapter AP-1 
and clathrin, albeit through different mechanisms. Rab4b directly recruits AP-1 as 
an effector to promote cargo sorting from early to recycling endosomes (53). 
Rab4a instead triggers a multistep GTPase cascade that in addition to AP-1, also 
recruits the clathrin adapters AP-3 and GGA3 to early endosomes (44). It is 
currently unclear if the variety of clathrin adapters recruited by Rab4a represents 
a functional diversity in Rab4a-mediated recycling. However, it is likely that the 
formation of recycling vesicles and tubules requires a larger protein machinery 
beyond the clathrin adapters and clathrin themselves, similar to the complexity 
seen for clathrin-mediated endocytosis (10, 13). The characterization of the 
protein machineries driving endocytic recycling will be crucial for the 
understanding of the functional divergence between different recycling pathways 
and their role for normal cell function.  
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We identified the adaptin-ear-binding coat-associated protein (NECAP) 
family during our proteomics analysis of clathrin-coated vesicles from adult rat 
brain (83, 97). The two members of the family, NECAP1 and NECAP2, share a 
high degree of sequence and structural similarity. At their N-terminus, the 
NECAPs encode a PH-like domain that functions as a protein binding module 
(37). In addition, NECAPs display peptides motifs at their C-terminus that 
promote interactions with the clathrin adaptors AP-1 and AP-2 (84). Our 
functional studies of NECAP1 revealed that NECAP1 functions together with AP-
2 in clathrin-mediated endocytosis at the cell surface (84). In fact, the NECAP1 
PH domain binds to some of the same accessory proteins interacting with AP-2 
such that NECAP1 and AP-2 cooperate in the recruitment of accessory proteins 
to the site of vesicle formation (84). NECAP1 depletion interferes with normal 
clathrin-mediated endocytosis, altering the number and size of forming vesicles 
and impairing clathrin-mediated internalization of ligand-bound EGFR (84).  
Notably, NECAP2 does not rescue the NECAP1 KD phenotype (84), 
suggesting that the two proteins are functionally divergent. Here, we provide the 
first functional characterization of NECAP2 and establish a role for NECAP2 in 
the fast recycling pathway. We demonstrate that NECAP2 is essential for the 
recruitment of AP-1/clathrin to early endosomes and the efficient recycling of 
EGFR and TfnR. Taken together, our results identify NECAP2 as a central 
component of the protein machinery for fast recycling.  
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Results 
The Human Protein Atlas indicates a broad protein expression pattern of 
NECAP2, with higher levels in several tissues including breast, kidney, and lung. 
We thus decided to use protein knock-down (KD) in MCF10A cells, which are 
adherent normal breast epithelial cells, as well as in the commonly used cell lines 
HeLa and COS-7 to define the function of NECAP2. 
 
NECAP2 does not regulate the size and number of endocytic clathrin 
coated pits 
To test if NECAP2 depletion causes changes in the number and size of 
endocytic clathrin-coated pits and vesicles similar to NECAP1 KD (84), we 
labeled these structures using the endocytosis-specific clathrin adapter AP-2 in 
control cells and cells depleted of NECAP1 or NECAP2 (Fig. 3.1A,B). The 
immunofluorescence signal intensity of the coat proteins AP-2 and clathrin is 
directly correlated to the size of the forming structure (84, 98–100). As expected, 
NECAP1 KD causes a decrease in the number and an increase in the 
intensity/size of AP-2-labeled puncta, whereas NECAP2 depletion has no effect 
(Fig. 3.1B-D). Thus, in contrast to NECAP1, NECAP2 is not required for the 
control of the number and size of clathrin-coated pits and vesicles at the plasma 
membrane.  
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Figure 3.1 - NECAP2 does not regulate endocytic clathrin-coated pits. (A) 
Western blot analysis of NECAP1 and NECAP2 expression levels in total protein 
lysates of control, NECAP1, and NECAP2 KD cells. The arrow head indicates the 
NECAP2-specific band. CHC: clathrin heavy chain. (B) Confocal images of 
endogenous AP-2 expression in control, NECAP2 KD and NECAP1 KD cells as 
indicated. Scale bar equals 15 µm in the low and 3 µm in the high magnification 
images. (C,D) Quantification of the number of AP-2 puncta per 250 µm2 (C) and 
fluorescence intensity per AP-2 punctum (D), mean ± s.e.m., N=3 experiments, 
n=17 cells total per condition. A. U.: arbitrary units. Statistical analysis using One-
Way ANOVA followed by Dunnett’s post-tests revealed significant differences 
between control and KD cells for (C,D), ** = p<0.01, *** = p<0.001.  
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NECAP2 does not affect clathrin-mediated endocytosis  
We next sought to test for changes in clathrin-mediated endocytosis. TfnR 
is constitutively internalized through clathrin-mediated endocytosis and recycles 
to the plasma membrane through both the fast and slow recycling pathway. 
Using fluorescence imaging, we first quantified the amount of fluorescently 
labeled transferrin internalized into MCF10A and HeLa cells within one minute  
 (min). This timeframe ensures analysis of endocytic events and excludes 
potential secondary effects due to changes transferrin/TfnR recycling. These 
assays revealed no differences in transferrin uptake between control, NECAP1 
KD and NECAP2 KD cells (Fig. 3.2A-C). To verify these results under different 
experimental conditions, we labeled the surface pool of TfnR by incubating COS-
7 cells with Alexa647-labeled transferrin on ice and then shifted the cells to 37°C 
for 1 or 4 min. After removal of residual transferrin from the cell surface by acid 
wash, cells were lysed and total protein extracts were separated by SDS-PAGE 
for quantification of internalized Alexa647-transferrin by quantitative infrared 
fluorescence measurement using an Odyssey Imaging System (LI-COR 
Biosciences). These assays confirmed that depletion of NECAP1 or NECAP2 
does not affect the rate of transferrin internalization at the purely endocytic 1 min 
time point (Fig. 3.2E,F). Interestingly, NECAP2 KD results in increased 
transferrin levels at the 4 min time point compared to control and NECAP1 KD 
cells (Fig. 3.2E,F), suggesting a role of NECAP2 in transferrin sorting subsequent 
to internalization. 
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Figure 3.2 - NECAP2 is not required for clathrin-mediated endocytosis of 
TfnR. (A,B) Fluorescence analysis of 1 min transferrin-Cy3 uptake in control, 
NECAP1 KD, and NECAP2 KD MCF10A cells(A) and HeLa cells (B). (C) 
Quantification of (A), mean ± s.e.m., N=3 experiments, n=35-55 cells total per 
group. A. U.: arbitrary units. (D) Quantification of (B) as a ratio of internalized 
over surface intensity of transferrin-Cy3, mean ± s.e.m., N=3 experiments, 
n=125-142 cells total per group. (C,D) Statistical analysis using One-Way 
ANOVA followed by Dunnett’s post-tests revealed no significant differences. (E) 
Quantitative infrared fluorescence measurement analysis of transferrin-Cy3 
levels and Western blot analysis of clathrin expression levels in total protein 
lysates of control, NECAP2 KD, and NECAP1 KD COS-7 cells. For each group, 
cells were either left untreated (no transferrin), incubated with transferrin-Cy3 on 
ice to label the TfnR surface pool (surface), or surface-labeled followed by 
transferrin internalization for 1 or 4 min at 37ºC as indicated. CHC: clathrin heavy 
chain. (F) Quantification of (E), mean ± s.e.m., N=3 experiments. Statistical 
analysis using Repeated-measures Two-Way ANOVA followed by Bonferroni 
post-tests revealed no differences at the 1 min time point and between control 
and NECAP1 KD cells at the 4 min time point, and significant differences 
between control and NECAP2 KD cells at 4 minute uptake time point, ** = 
p<0.01.  
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Figure 3.3 - NECAP2 is not required for clathrin-mediated endocytosis of 
EGFR. (A) Fluorescence analysis of EGF levels on the cell surface and 
internalized within 2.5 min in control, NECAP2 KD, and NECAP1 KD COS-7 cells 
using 2ng/ml EGF-Alexa647. Scale bar equals 20 µm. (B) Quantification of 
fluorescence intensity of EGF-Alexa647 on the cell surface, mean ± s.e.m., N=3 
experiments, n=75-103 cells per group. A.U.: arbitrary units. (C) Quantification of 
the fraction of surface EGF-Alexa647 internalized within 2.5 min, N=3 
experiments, n=114-155 cells per group. (B,C) Statistical analysis using 
Repeated-measures One-Way ANOVA followed by Dunnett’s post-tests revealed 
significant differences between control and NECAP2 KD cells for (B) and 
between control and NECAP1 KD cells in (C), ** = p<0.01, *** = p<0.001 
.  
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We previously showed that NECAP1 KD does not affect transferrin 
internalization, which is consistent with the data presented here, but decreases 
the clathrin-mediated endocytosis of ligand-bound EGFR in COS-7 cells (84). To 
test if NECAP2 plays a role in EGFR internalization, we incubated COS-7 cells 
on ice with fluorescently labeled EGF and then shifted the cells to 37°C for 2.5 
min to allow internalization, followed by removal of residual EGF from the cell  
surface by acid wash. The amount of surface-bound and internalized EGF was 
then quantified by fluorescence microscopy. These assays revealed differential 
effects of NECAP1 and NECAP2 on EGFR surface levels and internalization. 
NECAP1 KD does not alter EGFR surface levels but impairs EGF internalization 
(Fig. 3.3), consistent with our previous results. In contrast, NECAP2 KD cells 
display lower levels of EGFR on the surface (Fig.3.3A,B) even though total 
EGFR expression levels are comparable to control cells (Fig. 3.4C,D), 
suggesting that NECAP2 KD leads to a redistribution of EGFR within the cell. 
However, the percentage of surface EGFR internalized in NECAP2 KD cells is 
comparable to that of control cells (Fig. 3.3C). Together with the lack of effect on 
transferrin internalization, these results demonstrate that NECAP2 does not 
control clathrin-mediated endocytosis of TfnR and EGFR.   
 
NECAP2 depletion leads to enlarged early endosomes  
Using immunofluorescence analysis of endogenous markers, we 
discovered that NECAP2 KD causes a significant increase in the size of 
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Figure 3.4 - Early endosomal enlargement in NECAP2 KD cells. (A) Confocal 
images of the immunofluorescence analysis of endogenous EEA1 expression in 
MCF10A control, NECAP2 KD, and NECAP1 KD cells as indicated. Scale bar 
equals 10 µm. (B,E) Quantification of average early endosome size (B) and early 
endosome number per cell (E). (C) Western blot analysis of total protein lysates 
of control and NECAP2 KD cells for expression of various proteins as indicated. 
CHC: clathrin heavy chain. (D) Quantification of (C), mean ± s.e.m., N=3 
experiments. (B,D,E) Statistical analysis using One-Way ANOVA followed by 
Dunnett’s post-tests revealed significant differences between control and KD 
cells for (B,D), * = p<0.05, ** = p<0.01, *** = p<0.001. 
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Figure 3.5 – Changes in early endosomal size in NECAP2 KD cells. (A) 
Quantification of endosome size distribution for total number of endosomes, with 
y-axis reported in log scale. (B) Same data as (A), plotted as fold over control for 
each bin. (C,D) Confocal images of endogenous EEA1 in control and NECAP2 
KD COS-7 (C) and HeLa cells (D). Scale bars equal 15 µm in the low and 5 µm 
in the high magnification images. 
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early/sorting endosomes (Fig. 3.4A,B). Yet, NECAP2 KD does not alter EEA1 
expression levels or the total number of early endosomes per cell (Fig. 3.4C-E). 
Binning of early endosomes by size confirmed the prevalence of enlarged early 
endosomes due to NECAP2 depletion (Fig. 3.5A,B). Notably, we also observed 
similar changes in early endosomal morphology in COS-7 and HeLa cells 
following NECAP2 KD (Fig. 3.5C,D), indicating a general role for NECAP2 in the 
regulation of early endosomes. In contrast, NECAP1 KD has no effect on early 
endosomal morphology (Fig. 3.4A,B,E; Fig. 3.5A,B), confirming  that NECAP1 
and NECAP2 serve distinct cellular functions. 
Early endosomes receive endocytosed material from clathrin-dependent 
and -independent pathways and sort cargo toward recycling to the cell surface, 
retrograde transport to the Golgi, or degradation in lysosomes. Thus, larger 
endosomes may be the result of enhanced endocytic influx and/or a decrease in 
the rate of cargo recycling and/or degradation. Since clathrin-mediated 
endocytosis is the major endocytic pathway in eukaryotic cells (101) and 
NECAP2 depletion does not change the number of endocytic clathrin-coated pits 
(Fig. 3.1B-D) or the rate of clathrin-dependent internalization (Fig. 3.2A-F; Fig. 
3.3A-C), it is unlikely that changes in the endocytic potential contribute to the 
morphological changes of early endosomes in NECAP2 KD cells.  
 
NECAP2 controls EGFR cell surface levels and recycling 
Following internalization, EGFR enters early endosomes and either recycles  
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Figure 3.6 - NECAP2 shifts EGFR distribution from the cell surface to early 
endosomes. (A) Immunofluorescence analysis of the cell surface pool of 
endogenous EGFR in control and NECAP2 KD cells as indicated. Scale bar 
equals 20 µm. (B) Quantification of the fluorescence intensity of (A), mean ± 
s.e.m., N=3 experiments, n=123-136 cells total per group. A.U.: arbitrary units. 
(C) Immunofluorescence analysis of endogenous EGFR and EEA1 in control and 
NECAP2 KD cells as indicated. Scale bar equals 20 µm. (D) Quantification of the 
fraction of total EGFR signal intensity colocalizing with EEA1, mean ± s.e.m., 
N=3 experiments, n=77-92 cells per group. (B,D) Statistical analysis using One-
Way ANOVA followed by Bonferroni post-tests revealed significant differences 
between control and NECAP2 KD cells, * = p<0.05, ** = p<0.01.   
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back to the cell surface or enters into the degradative pathway. Since our EGF 
internalization assays suggested that NECAP2 regulates EGFR distribution 
within cells (Fig. 3.3A-C), we sought to further define the effects of NECAP2 KD 
on EGFR surface levels, localization and sorting. Labeling the cell surface pool of 
EGFR with an antibody directed against the extracellular region of the receptor 
revealed that NECAP2 KD leads to a 40% reduction in the surface levels of 
EGFR at steady state (Fig. 3.6A,B), consistent with the decreased levels of 
surface-bound EGF seen in NECAP2 KD cells (Figure 3.3A,B). Since Western 
blot analysis of total protein lysates from control and NECAP2 KD cells showed 
that NECAP2 depletion does not alter EGFR expression levels (Fig. 3.4C,D), we 
used coimmunofluorescence analyses to determine the distribution of EGFR 
within cells. These studies revealed that at steady state, EGFR accumulates in 
EEA1-positive endosomes upon NECAP2 depletion (Fig. 3.6C,D), suggesting 
that NECAP2 is required for efficient early endosomal sorting of EGFR. 
From early endosomes, EGFR is either recycled to the cell surface or sent 
for degradation and we thus sought to test for a role of NECAP2 in either sorting 
pathway. We first tested for changes in EGFR recycling after treatment with 
TGFα which leads specifically to EGFR recycling after the ligand dissociates from 
the receptor in early endosomes (71, 102). Control and NECAP2 KD cells were 
incubated with 10 nM TGFα for 5 min to trigger a wave of EGFR internalization, 
acid washed on ice and then chased for 3 or 5 min to allow for EGFR recycling. 
For each time point, cells were incubated on ice with an EGFR antibody directed  
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Figure 3.7 - NECAP2 controls EGFR recycling but not degradation. (A) 
Western blot analysis of surface EGFR, total EGFR, and AP-1 levels in control 
and NECAP2 KD HeLa cells with or without TGFα treatment as indicated. EGFR 
surface pools were antibody-labeled on ice prior to cell lysis and 
immunoprecipitation. (B) Quantitation of EGFR surface levels in (A), mean ± 
s.e.m., N=3 experiments. Statistical analysis using Two-Way ANOVA followed by 
Bonferroni post-tests revealed significant differences between control and 
NECAP2 KD cells for the 5 min chase, ** = p<0.01. (C) Quantification of the 
number of EGFR/EEA1-positive puncta in control and NECAP2 KD cells 
following stimulation with 1.5 ng/ml EGF, mean ± s.e.m., N=3, n=47-50 cells per 
group. Statistical analysis using One-Way ANOVA followed by Dunnett’s post-
tests revealed no significant differences. (D,E) Quantification of EGFR 
degradation in control and NECAP2 KD cells over time following stimulation with 
50 ng/ml (D) or 1.5 ng/ml EGF (E), mean ± s.e.m., N=3. Statistical analysis using 
Two-Way ANOVA followed by Bonferroni post-tests revealed no significant 
differences.  
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against the extracellular region to label the surface pool of EGFR, washed, lysed, 
and the fraction of antibody-bound EGFR was isolated by immunoprecipitation 
and detected by Western blot. These studies showed that the 3min chase does 
not allow for efficient EGFR recycling in control or NECAP2 KD cells since the 
receptor surface levels remains at comparable levels to that of EGFR remaining 
on the cell surface after the 5 min TGFα pulse (Fig. 3.7A,B). Since the rate of 
exocytosis from early endosomes varies from one to several minutes depending 
on the cell line, cargo and methods of analysis used (57, 95, 103), the 
vesicles/tubules that recycle EGFR from early endosomes may have not yet 
reached the cell surface after the 3 min chase. Alternatively, recycling may be 
slightly delayed in our experimental design due to the incubation on ice prior to 
the chase that is required to remove residual TGFα from the cell surface after the 
pulse. However, during the 5 min chase, control cells efficiently recycle EGFR to 
the cell surface (Fig. 3.7A,B). In contrast, EGFR surface levels in NECAP2 KD 
cells remain close to the level detected at the end of the TGFα pulse (Fig. 
3.7A,B), demonstrating that NECAP2 KD impairs fast EGFR recycling. 
Consistently, we detected an increase in the number of EGFR-containing EEA1-
positive endosomes in NECAP2 KD cells compared to control after treatment 
with 1.5 ng/ml EGF for 3 min (Fig. 3.7C), though this increase did not reach 
significance due to variability between experiments.  
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NECAP2 is dispensable for EGFR degradation 
To determine if NECAP2 KD also alters EGFR degradation, we tested for 
changes in total EGFR levels over time following ligand-induced internalization. 
Continuous stimulation with 50ng/ml EGF, which drives EGFR into the 
degradative pathway (104–106), leads to a 50% decrease of total EGFR levels 
within one hour (Fig. 3.7D). Though NECAP2 KD cells appear to show a slight 
delay, the rate of EGFR degradation during later time points is comparable 
between control and NECAP2 KD cells and we did not find a significant 
difference in the rate of EGFR degradation (Fig. 3.7D). We next tested if 
NECAP2 KD enhances the rate of EGFR degradation when cells are stimulated 
with low levels of EGF (1.5 ng/ml), which promotes EGFR recycling (106). Under 
these conditions, total EGFR levels remain nearly constant, dropping only to 95% 
of the starting levels during the one hour stimulation (Fig. 3.7E). Notably, we did 
not observe any differences in EGFR levels between control and NECAP2 KD 
cells (Fig. 3.7E). Together, these data show that EGFR accumulates in early 
endosomes following NECAP2 depletion due to impaired EGFR recycling. In 
contrast, NECAP2 is not required for endosomal cargo sorting into multivesicular 
bodies for receptor degradation. 
 
NECAP2 KD shifts TfnR into early endosomes 
We next tested if NECAP2 depletion also affects the recycling of the 
transferrin receptor (TfnR) and its ligand transferrin. TfnR is internalized through 
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Figure 3.8 – NECAP2 KD alter the intracellular distribution of TfnR. (A) 
Quantification of fluorescence intensity for the cell surface labelling of 
endogenous TfnR in control and NECAP2 KD cells, mean ± s.e.m., N=3 
experiments, n=85-101 cells per group. A. U.: arbitrary units. (B) Confocal 
images of endogenous TfnR with endogenous EEA1, Rab11a, and TGN46 in 
control and NECAP2 KD cells as indicated. Scale bar equals 15 µm. (C) 
Quantification of the fraction of total TfnR fluorescence signal colocalizing with 
the indicated markers, mean ± s.e.m., N=3 experiments, n=12 cells total per 
group and marker. (A,C) Statistical analysis using One-Way ANOVA followed by 
Dunnett’s post-tests revealed significant differences between control and 
NECAP2 KD cells for (C), * = p<0.05, ** = p<0.01, and no significant differences 
for (A).   
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clathrin-mediated endocytosis and recycles from early endosomes through the 
fast Rab4a-dependent and the slow Rab4b/Rab11a-dependent pathway. 
NECAP2 KD does not lead to changes in the cell surface levels of TfnR (Fig. 
3.8A). However, NECAP2 depletion results in increased total levels of TfnR (Fig. 
3.4B,C), suggesting that NECAP2 KD cells maintain normal receptor surface 
levels by upregulating TfnR expression. To test for changes in TfnR distribution, 
we quantified the percentage of TfnR that colocalized with markers for early 
endosomes (EEA1), recycling endosomes (Rab11a) and the trans-Golgi network 
(TGN46) in control and NECAP2 KD cells. We did not observe any changes in 
the amount of TfnR present in recycling endosomes or the trans-Golgi (Fig. 
3.8B,C). In contrast, following NECAP2 depletion, a significantly larger pool of 
TfnR accumulates in early endosomes (Fig. 3.8B,C), suggesting that NECAP2 
depletion also impairs TfnR recycling.  
 
NECAP2 KD has no effect on slow transferrin recycling 
To directly test for changes in TfnR recycling, we fed control and NECAP2 
KD cells with fluorescently-labeled transferrin for 70 min, stripped off the surface 
pool and followed the loss of transferrin-Cy3 over time. Samples were taken 
every 15 minutes to test for changes in the slow recycling pathway. Notably, 
NECAP2 KD cells gain significantly higher amounts of transferrin-Cy3 during the 
labeling pulse (detected by the 0 min time point of the chase, Fig. 3.9A), 
consistent with the higher levels of TfnR expression in NECAP2 KD cells (Fig. 
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3.4B,C). During recycling, NECAP2 KD cells maintain higher levels of transferrin-
Cy3 over time compared to control cells (Fig. 3.9A). However, replotting the 
curves by normalizing for starting levels of transferrin revealed that control and 
NECAP2 KD cells recycle transferrin-Cy3 with a similar rate and kinetics (Fig. 
3.9B), indicating that NECAP2 has no effect on the slow recycling of 
transferrin/TfnR.  
 
NECAP2 controls transferrin recycling along the fast recycling pathway 
The fast recycling pathway sends receptors back to the cell surface within 
minutes (57, 95, 103). As such, the rate of short-term internalization of 
transferrin-Cy3 transitions from a purely endocytic phase to a balance between 
endocytosis and fast recycling. NECAP2 depletion leads to enhanced 
accumulation of transferrin-Cy3 within 5 min of continuous labeling at 37°C (Fig. 
3.10A,B). Given that control and NECAP2 KD cells display similar levels of TfnR 
on the cell surface (Fig. 3.8A) as well as show no difference in the number of 
endocytic clathrin-coated pits and vesicles (Fig. 3.1B-D), transferrin and EGF 
internalization (Fig. 3.2; Fig. 3.3), and slow recycling (Fig. 3.9A,B), the 
intracellular accumulation of transferrin after 5 min uptake is thus likely the result 
of impaired fast recycling.  
To increase the temporal resolution of the assay, we analyzed the amount 
of intracellular transferrin-Cy3 every minute over a five minute period in MCF10A 
cells. During the first two minutes, we detected no difference in the amounts of 
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Figure 3.9 - NECAP2 does not control slow transferrin recycling. (A) 
Quantification of transferrin recycling in control and NECAP2 KD cells over time 
as measured by transferrin-Cy3 signal intensity, mean ± s.e.m., N=4 
experiments, n=66-137 cells per group and time point. Statistical analysis using 
Two-Way ANOVA followed by Bonferroni post-tests revealed significant 
differences between control and NECAP2 KD cells, * = p<0.05, *** = p<0.001. (B) 
Same data as shown in (A), plotted by adjusting the 0 min time point to a value of 
1 for each condition.  
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internalized transferrin-Cy3 between control and NECAP2 KD cells (Fig. 
3.10C,D). These time points likely reflect the purely endocytic phase (107, 108). 
By three minutes, transferrin begins to reach early endosomes and at this point, 
NECAP2 KD cells show a trend towards accumulating higher amounts of 
transferrin-Cy3, resulting in a significant build-up at later time points (Fig. 
3.10C,D). These results are consistent with the increase in internalized 
transferrin in COS-7 cells detected by quantitative infrared fluorescence 
measurement only at the longer 4 min time point but not at the solely endocytic 1 
min time point (Fig. 3.2E,F). Together, these data further support a role for 
NECAP2 in the fast recycling pathway. 
We next sought to directly test for changes in fast recycling. For this, we 
labeled control and NECAP2 KD MCF10A cells with transferrin-Cy3 for 5 min at 
37ºC, which is enough time for transferrin to reach early endosomes, stripped off 
any surface label by acid washing on ice, and chased cells with pre-warmed 
regular medium. Each minute, aliquots of cells were acid washed on ice, fixed 
and the amount of transferrin-Cy3 remaining in the cells was quantified by 
fluorescence microscopy. These assays revealed that NECAP2 KD causes a 
significant delay in transferrin recycling within the first few minutes of the chase 
(Fig. 3.11A,B), directly demonstrating that NECAP2 controls fast recycling. 
Moreover, NECAP2 also impairs fast transferrin recycling in HeLa and COS-7 
cells (Fig. 311C-F), confirming that NECAP2 is a general regulator of the fast 
recycling pathway.   
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Figure 3.10 - Transferrin accumulates in NECAP2 KD cells. (A) Fluorescence 
analysis of transferrin-Cy3 internalization within 5 min into control and NECAP2 
KD cells as indicated. Scale bar equals 10 µm. (B) Quantification of fluorescence 
intensity for (A), mean ± s.e.m., N=4 experiments, n=142-156 cells total per 
group. Statistical analysis using One-Way ANOVA followed by Dunnett’s post-
tests revealed significant differences between control and NECAP2 KD cells for 
(C), * = p<0.05, (C) Fluorescence analysis of transferrin-Cy3 internalized over 
time by control and NECAP2 KD cells as indicated. Scale bar equals 10 µm. (D) 
Quantification of signal intensity for (C) and of additional time points, mean ± 
s.e.m., N=3 experiments, n=60-160 cells total per group and time point. 
Statistical analysis using Two-Way ANOVA followed by Bonferroni post-tests 
revealed significant differences between control and NECAP2 KD cells, ** = 
p<0.01. 
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NECAP2 is essential for AP-1 recruitment to early endosomes. 
AP-1 and clathrin mediate receptor transport from early endosomes and the 
Golgi. On early endosomes, AP-1 is involved in both the fast and slow recycling 
pathway and is recruited downstream of Rab4a and Rab4b, respectively (44, 53). 
Since NECAP1 depletion affects AP-2-positive forming vesicles at the cell 
surface and NECAP2 binds AP-1 (84, 86), we used immunofluorescence studies 
to test if NECAP2 depletion affects the recruitment of AP-1 to early endosomes. 
Control MCF10A cells show the prominent Golgi-associated pool of AP-1 and 
discrete AP-1-positive puncta in the periphery of the cell that are also positive for 
EEA1 (Fig. 3.12A). NECAP2 KD cells maintain the Golgi pool of AP-1 (Fig. 
3.12A) and show no differences in the total expression levels of AP-1 and clathrin 
compared to control cells (Fig. 3.4B,C; Fig 3.12B). However, NECAP2 depletion 
leads to a selective loss of AP-1 from early endosomes (Fig. 3.12A,C). 
Consistently, we also observe a selective loss of AP-1 from early endosomes in 
HeLa and COS-7 cells (Fig. 3.12D,E). Thus, NECAP2 is required for the efficient 
recruitment of the AP-1/clathrin machinery to early endosomes to facilitate 
receptor recycling.  
 
Multiple binding interfaces in NECAP2 are required for AP-1 recruitment to 
early endosomes. 
To determine how NECAP2 controls AP-1 recruitment to early endosomes 
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Figure 3.11 - NECAP2 controls transferrin recycling through the fast recycling pathway. (A,C,E) 
Immunofluorescence analysis of transferrin-Cy3 recycling over time in control and NECAP2 KD MCF10A (A), HeLa 
(C) and COS-7 cells (E). Scale bars equal 20 µm. (B,D,F) Quantitation of (A,C,E), mean ± s.e.m., N=3 
experiments, n=8-29 cells per condition per time point for (B), n=10-23 cells per condition per time point for (D), 
and n=4-14 cells per condition per time point for (F). (B,D,F) Statistical analysis using Two-Way ANOVA followed 
by Bonferroni post-tests revealed significant differences between control and NECAP2 KD cells, * = p<0.05, ** = 
p<0.01, *** = p<0.001.
 71 
 
and fast recycling, we performed rescue experiments with NECAP2 wild-type and 
point mutants. Re-expression of wild-type NECAP2 rescues the peripheral 
punctate pool of AP-1, though AP-1 levels are not fully restored (Fig. 3.13A,B). 
We have noticed that overexpression of NECAP2 result in a mislocalization of 
several NECAP2 binding partners, including AP-1 (data not shown). Thus, 
though we tightly controlled the expression levels of our rescue constructs by 
using lentiviral delivery and excluded cells with high expression levels from the 
analysis, a fraction of the cells likely expressed either too little or too much 
NECAP2 to achieve complete rescue.   
Notably, NECAP2 variants in which the C-terminal AP-1-binding motif or 
the N-terminal PH domain are inactivated, fail to rescue the KD phenotype (Fig. 
3.13A,B). We used co-immunoprecipitation to confirm that all rescue constructs, 
with the exception of the AP-1 motif mutant, interact with AP-1 to a similar level 
(Fig. 3.13C), excluding side-effects of the point mutations on NECAP2 folding 
and stability. Together, these data demonstrate that the ability of NECAP2 to 
interact with the AP-1 γ-ear and with PH domain binding partners is essential for 
NECAP2 function. This further suggests a central role for NECAP2 in the 
formation of a protein network that promotes recycling vesicle formation on early 
endosomes and fast receptor recycling (Fig. 3.14). Finally, expression of wild-
type NECAP1 does not rescue the NECAP2 KD phenotype (Figure 3.13A,B), 
providing further proof that the two mammalian NECAP family members are 
functionally divergent.   
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Figure 3.12 - NECAP2 is essential for AP-1 recruitment to early endosomes. 
(A,D,E) Immunofluorescence analysis of endogenous AP-1 and EEA1 in control 
and NECAP2 KD MCF10A (A), HeLa (D) and COS-7 cells (E). Arrow heads 
indicate structures labeled by both proteins. Scale bars equal 15 µm in the low 
and 5 µm in the high magnification images. (B) Quantification of total intensity 
levels of endogenous AP-1 by immunofluorescence analysis in control and 
NECAP2 KD MCF10A cells, mean ± s.e.m., N=3 experiments, n=15 cells total 
per group. A. U.: arbitrary units. (C) Quantification of the fraction of endogenous 
AP-1 signal intensity colocalizing with endogenous EEA1-positive early 
endosomes in control and NECAP2 KD MCF10A cells, mean ± s.e.m., N=3. 
(B,C) Statistical analysis using One-Way ANOVA followed by Dunnett’s post-
tests revealed significant differences between control and NECAP2 KD cells for 
(C), *** = p<0.001, and no significant differences for (B). 
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Discussion 
The NECAP proteins show a high degree of sequence similarity and share a 
common structural organization including two peptide motifs for interaction with 
the clathrin adapter proteins AP-1 and AP-2 (37, 83, 86). Yet, we recently 
showed that NECAP1 cooperates with AP-2 to ensure efficient vesicle formation 
for clathrin-mediated endocytosis (84), while the data presented here 
demonstrate a central role for NECAP2 in AP-1-mediated fast recycling from 
early endosomes. In addition, each NECAP fails to rescue the KD phenotype of 
the other family member (Fig. 3.13A,B) (84). Together, these data demonstrate 
that NECAP1 and NECAP2 have functionally diverged to selectively regulate 
clathrin-mediated sorting at distinct cellular locations. Future studies into the 
molecular determinants that link the NECAPs into their respective pathway may 
begin to unravel how related protein machineries adapt to fulfill similar yet distinct 
functions at different localizations within the cell.   
Casanova and colleagues recently deciphered a small GTPase cascade 
downstream of Rab4a for AP-1 recruitment to early endosomes (44). Active 
Rab4a leads to the recruitment and activation of Arl1 at early endosomes and the 
subsequent recruitment of the Arl1 effector proteins BIG1 and BIG2. The BIGs 
then function as GEFs for Arf1 and Arf3, which in turn recruit AP-1 (44). Since 
NECAP2 depletion leads to a loss of AP-1 from early endosomes, it will be 
interesting to determine if NECAP2 is required for full activation of this GTPase 
cascade. Alternatively, NECAP2 could be part of a second mechanisms 
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Figure 3.13 - The PH domain and AP-1-binding motif of NECAP2 are critical 
for AP-1 recruitment to early endosomes. (A) Immunofluorescence analysis of 
endogenous AP-1. The top three panels of each image (left to right) show the 
soluble GFP marker for transduction with control and NECAP2 KD viruses in 
blue, endogenous AP-1 in green, and the RFP signal of rescue constructs in red 
as indicated. The bottom panel of each image shows the magnified area outlined 
in white in the AP-1 panel. The scale bar equals 2 µm. (B) Quantification of total 
levels of endogenous AP-1 intensity by immunofluorescence analysis in control, 
NECAP2 KD and NECAP2 KD+rescue cells, mean ± s.e.m., N=3 experiments, 
n=30 cells per group. Results displayed as AP-1 intensity per area of cell (µm2). 
Analysis was performed by subtracting the Golgi pool of AP-1 from analysis to 
account for only endosomal puncta. Co-staining for early endosome marker 
could not be performed due to lack of additional channels for image acquisition. 
Statistical analysis using One-Way ANOVA followed by Dunnett’s post-tests 
revealed significant differences between NECAP2 KD and control or NECAP2 
wildtype rescue cells, *** = p<0.001, and no significant differences between 
NECAP2 KD cells and cells rescued with NECAP2 PH mutant, NECAP2 AP-1 
mutant, or NECAP1. (C) Western blot analysis of co-immunoprecipitation of AP-1 
with various Flag-tagged NECAP variants as indicated. Lysate equals 10% of the 
total protein lysate used for the IP (immunoprecipitation).   
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contributing to and required for AP-1 recruitment to early endosomes. Our rescue 
studies revealed that NECAP2 function depends on the C-terminal AP-1-binding 
motif and the protein-binding interface of the N-terminal PH domain. In NECAP1, 
the PH domain allows for efficient recruitment of endocytic accessory proteins to 
the forming vesicle and loss of PH domain function is sufficient to impair vesicle 
formation (84). It is thus tempting to speculate that the PH domain of NECAP2 
fulfills a similar role during recycling vesicle formation at early endosomes. 
Here,the effect of loss of NECAP2 or PH domain-mediated interactions is more 
severe, leading to the loss of AP-1 from the organelle. This may reflect a less 
complex protein machinery involved at early endosomes, compared to the 
endocytic clathrin machinery at the plasma membrane. In this scenario, depletion 
of a single component such as NECAP2 would lower the chance of successful 
coincidence detection within the protein network and imbalance the formation of 
the clathrin coat.   
Interestingly, the Rab4a GTPase cascade also promotes the recruitment 
of additional clathrin adapters, AP-3 and GGA3 (44). It remains currently 
unknown if this reflects the cooperation and/or interdependency of different 
clathrin adapters during recycling vesicle formation similar to the AP-1-dependent 
association of GGA2 with clathrin-coated vesicles and the cooperation of AP-1 
and GGAs in mannose-6-phosphate receptor sorting in mammalian cells, and the 
GGA2-supported recruitment of AP-1 to the trans-Golgi network in yeast (109–
111). 
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Figure 3.14 - Model of NECAP2 function. The left panel depicts AP-1 recruitment to early endosomes in the 
presence of NECAP2.  NECAP2 interacts with the AP-1 γ-ear through the C-terminal AP-binding motif while the 
NECAP2 PH promotes interactions with accessory protein for recycling vesicle formation. In the absence of 
NECAP2 (right panel), AP-1 has less affinity for early endosomes, leading to impaired recruitment and fast 
recycling.  
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Alternatively, the involvement of multiple adapters could increase the variety of 
cargo utilizing the Rab4a pathway. For example, in polarized epithelial cells, the 
two AP-1 variants, AP-1A and AP-1B, bind cargo with different affinities, thereby 
promoting differential sorting (112). Interestingly, in vitro binding studies suggest 
that NECAP2 also interacts with GGA1 and GGA2 (87), while it currently remains 
unknown if NECAP2 also interacts with GGA3. We have not detected any 
changes in GGA3 localization due to NECAP2 depletion, though this aspect will 
require further investigation with improved reagents for GGA3.  
Cargo sorting into the endocytic recycling pathways has been considered 
a signal-independent default route for receptors. The high surface to volume ratio 
of newly-formed vesicles and tubules is thought to allow for geometry-based 
sorting of membrane-bound molecules away from soluble material or receptors 
actively retained in the early endosomal lumen (55, 113–115). To date, a more 
detailed understanding of the contributions of Rabs, Arfs and sorting nexins to 
receptor sorting suggests that recycling pathways and/or machineries can create 
cargo selectivity. For example, Rab25 differentially recycles integrin dependent 
on the activation state of the receptor (116). On early endosomes, Rab35 and 
Arf6 counter-regulate each other to balance Rab35-dependent cadherin and 
Arf6-dependent integrin recycling (5). In addition, Rab4a and Arf6 cooperate for 
the recycling of Met receptor (45). It will be interesting to see if NECAP2 
functions in all Rab4a-mediated recycling events or with a specific subset of 
clathrin adaptors and/or cargo.
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 CHAPTER IV – NECAP2 ORGANIZES A RAB4A-MEDIATED FAST 
RECYCLING PATHWAY IMPORTANT FOR CELL MIGRATION AND 
CANCER CELL INVASION  
Introduction 
Metastasis is a direct result of increased cancer cell migration and 
invasion, and is the main cause of breast cancer related mortality (117). Cell 
migration and invasion are complex processes that depend on the interactions 
between integrins on the cell surface and the extracellular matrix (118, 119). 
Integrin β3 is one such integrin that contributes to breast cancer aggressiveness 
and is amplified in up to 25% of breast cancers (73, 118). The Rab4a-driven 
recycling of integrin αvβ3 from EEs to the leading edge controls persistent cell 
migration (49, 80, 120–122) and breast cancer invasion and metastasis (72, 73).  
Stimulation of cells with growth factors such as PDGF causes 
phosphorylation/activation of protein kinase D (PKD1) and subsequent PKD1 
association with integrin β3 located in early endosomes (77, 80). Activated PKD1 
then recruits and phosphorylates rabaptin-5 to promote Rab4a-mediated fast 
recycling of integrin αvβ3 to the leading edge of cells (78). There, integrin αvβ3 
activates the small GTPase Rac1 and promotes lamellipodia formation and 
persistent directional cell migration (80, 123). In addition, crosstalk between the 
Rab4a-mediated fast recycling of integrin αvβ3 and the Rab11-mediated slow 
recycling pathway results in decreased recycling of integrin α5β1 (70, 80). The 
resulting decrease in integrin α5β1 levels at the cell surface leads to decreased 
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activation of RhoA and its downstream kinase ROCK (124). This leads to a 
decrease in the inhibitory phosphorylation of cofilin, resulting in enhanced actin 
turnover and random cell migration (80, 81, 125, 126). It has been reported that 
when integrin αvβ3 recycling is inhibited, the negative feedback on integrin α5β1 
slow recycling is released, allowing cells to switch from integrin αvβ3-driven 
persistent directional migration to integrin α5β1-dependent random migration (80, 
127).  
The Rab4a-driven fast recycling pathway engages numerous clathrin 
adaptors and downstream effector proteins in order to control receptor recycling 
(44, 67). The recruitment of the clathrin adaptors depends on Rab4a-mediated 
recruitment and activation of Arf1 on EE, which serves as a docking site for AP-1, 
AP-3, and GGA3 (44). These adaptors then command the formation of transport 
carriers and the sorting of cargo receptors, e.g. TfnR recycling is mediated by 
AP-1 while Met receptor recycling depends on GGA3 (44, 45). Interestingly, 
Rab4a also works in conjunction with the retromer component Vps35 for 
recycling of β2AR (67). The plethora of effector proteins functioning downstream 
of Rab4a suggests that different effectors establish individual sub-routes that 
could serve to recycle distinct cargo receptors and/or regulate distinct cellular 
functions. However, the manipulation of a single sub-route within the Rab4a 
pathway has thus far been hampered by the fact that the clathrin adaptors and 
Vps35 also function in cargo of transport to and from the Golgi. 
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We recently identified NECAP2 as a new regulator AP-1-mediated fast 
recycling from early endosomes. Here we show that NECAP2 selectively controls 
AP-1-mediated receptor recycling along the Rab4a recycling pathway, with no 
effect on AP-1 function at the Golgi or on other effector proteins downstream of 
Rab4a. NECAP2 is thus the first example of a sub-route specific regulator within 
the fast recycling pathway. Furthermore, we demonstrate that NECAP2 function 
is critical for the fast recycling of integrin αvβ3 and for integrin αvβ3-dependent 
migration and cancer cell invasion. Our data thus identify NECAP2/AP-1-
mediated fast recycling as the sub-route responsible for Rab4a- and integrin β3-
driven invasion and metastasis, and may provide a foundation for new 
therapeutic approaches, in particular for the treatment of breast cancers with 
Rab4a and integrin β3 amplification (72, 73). 
 
Results 
NECAP2 functions within the Rab4a recycling pathway 
 We have recently shown that NECAP2 causes changes in TfnR and 
EGFR recycling consistent with a role in fast recycling (128). Since fast recycling 
of TfnR has been shown to involve AP-1 and Rab4a (40, 96), our previous 
studies suggest that NECAP2 functions within the Rab4a fast recycling pathway. 
To address whether NECAP2 works together or in parallel with Rab4a we tested 
for changes in TfnR trafficking in NECAP2 KD, Rab4a KD, and NECAP2/Rab4a 
double KD cells. Cells were either surface labelled or fed with fluorescently  
 83 
 
 
Figure 4.1 - NECAP2 functions in Rab4a-mediated fast recycling. (A) 
Fluorescence analysis of transferrin-Alexa647 accumulation within 5 min in 
control NECAP2 KD, Rab4a KD, and NECAP2/Rab4a double KD MCF10A cells 
as indicated. Scale bar equals 20 µm. (B) Quantification of fluorescence intensity 
for (A), mean ± s.e.m., N=3 experiments, n=153-212 cells total per group. A.U.: 
arbitrary units. (C) Quantification of fluorescence intensity for cell surface bound 
transferrin-Alexa647, mean ± s.e.m., N=3 experiments, n=150-171 cells total per 
group. A.U.: arbitrary units. (B,C) Statistical analysis using Two-Way ANOVA 
followed by Bonferroni post-tests revealed significant differences between control 
and KD cells, *** = p<0.001. 
  
 84 
conjugated Tfn for 2.5 and 5 minutes, and the intracellular accumulation of Tfn 
was measured over time as previously described (128). During this time frame, 
the amount of Tfn present in cells reflects the balance between the rate of 
internalization and the rate of fast recycling. We have previously shown that 
NECAP2 KD has no effect on TfnR internalization and that the increase of 
intracellular Tfn is the result of impaired recycling (128). Cell surface labelling 
revealed no differences in TfnR levels at the plasma membrane between control 
and KD cells (Fig. 4.1A). As expected, knock-down of NECAP2 or Rab4a KD 
impairs Tfn recycling at early time points (Fig. 4.1B,C) summary of data, e.g. 
consistent with Rab4a and NECAP2 functioning in the same pathway. 
Importantly, Tfn accumulation in NECAP2/Rab4a double KD cells is similar to 
that seen with individual KDs alone (Fig. 4.1B,C). Together, our data show that 
NECAP2 is a key regulator for Rab4a-mediated fast recycling Tfn recycling. 
 
NECAP2 selectively functions with AP-1  
 We have previously shown that NECAP2 is essential for the recruitment of 
AP-1 to EEs (128), however, it has yet to be determined if NECAP2 also controls 
the recruitment of other Rab4a effectors and clathrin adaptors. We thus tested for 
changes in AP-3, GGA1, GGA3, and Vps35 recruitment to EEA1-positive early 
endosomes between control and NECAP2 KD cells using immunofluorescence 
(Fig. 4.2A-E). Due to limitations of antibodies we transiently transfected myc-
tagged GGA1 and Flag-tagged GGA3, and used antibodies again endogenous  
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Figure 4.2 - NECAP2 selectively controls AP-1 recruitment to early 
endosomes (A-E) Immunofluorescence analysis of endogenous AP-1 (A), AP-3 
(B), myc-tagged GGA1 (C), Flag-tagged GGA3 (D), endogenous Vps35 (E)  
EEA1 in control and NECAP2 KD MCF10A cells. Arrow heads indicate structures 
labeled by both. Scale bars equal 20 µm in the low and 5 µm in the high 
magnification images.(F) Quantification of (A-E) for the fraction of AP-1, AP-3, 
GGA1, GGA3, and Vps35 signal intensity colocalizing with peripheral EEA1-
positive early endosomes in control and NECAP2 KD cells, mean ± s.e.m., N=3. 
(F) Statistical analysis using One-Way ANOVA followed by Dunnett’s post-tests 
revealed significant differences between control and NECAP2 KD cells for AP-1, 
*** = p<0.001, and no significant differences for other markers. (G) Quantification 
of immunofluorescence analysis in (A-E) for the percentage of cells with pools of 
each marker at the Golgi. Statistical analysis using One-Way ANOVA followed by 
Dunnett’s post-tests revealed no significant differences. 
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AP-1, AP-3, and Vps35. As reported before, NECAP2 KD causes a loss of AP-1 
from EEs (128) (Fig. 4.2A,F). In contrast, NECAP2 KD had no effect on the 
recruitment of the other clathrin adaptors or Vps35 to EE (Fig. 4.2B-F). 
Therefore, NECAP2 functions exclusively with AP-1 in Rab4a-mediated fast 
recycling. 
 
NECAP2 depletion does not impair clathrin adaptor or Vps35 recruitment at 
the Golgi 
 In addition to their role in EE sorting, the clathrin adaptors and Vps35 
function in protein transport to and from the Golgi (28, 41, 44, 129). To determine 
if NECAP2 also regulates recruitment to the Golgi we used immunofluorescence 
imaging to quantify the percentage of cells showing accumulation of the different 
markers in the perinuclear Golgi region. These studies revealed that NECAP2-
depleted cells maintain a Golgi pool of all markers, indicating that NECAP2 KD 
does not affect sorting to and from the Golgi, but selectively impairs AP-1-
mediated fast recycling from EEs (Fig 4.2G). Together, these data identify 
NECAP2 as the first sub-route specific regulator within the Rab4a-mediated fast 
recycling pathway. 
 
NECAP2 functions downstream of Arf1 in AP-1 recruitment. 
  A main mechanism of recruitment for the clathrin adaptors AP-1, AP-3, 
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Figure 4.3 - NECAP2 does not control Arf1 dependent recruitment of 
clathrin adaptors. Immunofluorescence analysis of endogenous AP-1 (top row) 
and AP-3 (bottom row) in control and NECAP2 KD cells. Cells were treated with 
the Arf1 GEF inhibitor BFA, as indicated, at 10µg/ml for 20 min. Scale bar equal 
to 20 µm.  
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and GGA3 to EE and to the Golgi is through binding of active Arf1 (44, 130). We 
thus sought to determine if NECAP2 KD alters the activation state of Arf1 on  
EEs. Control and NECAP2 KD cells were treated with the Arf1 GEF inhibitor 
brefeldin A (BFA) to cause Arf1 inactivation, which results in clathrin adaptor 
dispersion from both the Golgi and EEs. As expected, in untreated control cells 
AP-1 and AP-3 localize to peripheral endosomes and the perinuclear Golgi while 
only AP-1 is selectively lost from EEs in NECAP2 KD cells (Fig. 4.3). BFA 
treatment causes the dissociation of AP-1 and AP-3 from both organelles in 
control cells (Fig. 4.3), consistent with the critical role of active Arf1 in adaptor 
recruitment to membranes. Notably, Arf1 inactivation by BFA in NECAP2 KD 
cells also causes a loss of AP-3 from EEs, as well as loss of AP-1 and AP-3 from 
the Golgi (Fig. 4.3) demonstrating that Arf1 activation on EEs is sustained in 
NECAP2 KD cells at levels sufficient for adaptor recruitment. Thus, the loss of 
AP-1 from EE in NECAP2 KD cells is not due to a loss of the EE pool of active 
Arf1, indicating a role for NECAP2 in later steps of AP-1 carrier formation. 
 
Multuple regions in the NECAP2 protein sequence are essential for AP-1 
recruitment to EEs 
 We have previously shown that NECAP1 fails to rescue the loss of AP-1 
from EE in NECAP2 KD cells (128) despite the high degree of similarity between 
the NECAP family members. To identify the protein region(s) essential for 
NECAP2 function in fast recycling, we created a series of protein chimeras in
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Figure 4.4 - Multipe regions of NECAP2 are necessary for AP-1 localization 
to early endosomes. (A) Graphic representation of NECAP1 and NECAP2 
protein structure. PH: PH domain, Ex: extended conserved region, AP-1: AP-1 
binding WxxF motif, AP-2: AP-2 binding WxxF motif. Numbers indicate amino 
acid positions. PH chimera: NECAP2 PH domain replaced with that of NECAP1, 
Ex chimera: NECAP2 Ex region replaced with that of NECAP1, C-term chimera: 
NECAP2 C-terminus replaced with that of NECAP1. (B) Immunofluorescence 
analysis of endogenous AP-1 in control and NECAP2 KD cells expressing 
various constructs as indicated. The top three panels of each image (left to right) 
show the soluble GFP marker for transduction with control and NECAP2 KD 
viruses in blue, endogenous AP-1 in green, and the RFP signal of rescue 
constructs in red as indicated. The bottom panel of each image shows the 
magnified area outlined in white in the AP-1 panel. The scale bar equals 2 µm. 
(C) Quantification of total levels of endogenous AP-1 intensity by 
immunofluorescence analysis in control, NECAP2 KD and NECAP2 KD cells 
expressing various constructs as indicated, mean ± s.e.m., N=3 experiments, 
n=30 cells per group. Results displayed as AP-1 intensity per area of cell (µm2). 
Analysis was performed by subtracting the Golgi pool of AP-1 from analysis to 
account for only endosomal puncta. Co-staining for early endosome marker 
could not be performed due to lack of additional channels for image acquisition. 
Statistical analysis using One-Way ANOVA followed by Dunnett’s post-tests 
revealed significant differences for some conditions as indicated, *** p= <0.001, 
n.s. not significant. 
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which either the PH domain, the extended conserved region, or the C-terminal of 
NECAP2 were replaced with the corresponding regions of NECAP1 (Fig. 4.4A). 
The chimeras were then tested for their ability to rescue the loss AP-1 from EE in 
NECAP2 KD as described before (128). Consistent with our previous results, 
expression of wild-type NECAP2 reversed the AP-1 phenotype in NECAP2 KD 
cells while wild-type NECAP1 failed to rescue (Fig. 4.4B,C) (128). Notably, all 
chimeras also failed to rescue the NECAP2 KD phenotype (Fig. 4.4B,C). These 
data reveal that there are molecular determinants in all three regions of NECAP2 
that are essential for its role in fast recycling. This result is particularly surprising 
for the C-term chimera since the AP-1 binding motifs of NECAP1 and NECAP2 
allow for equivalent AP-1 binding in vitro (86). Given the role of the PH domain 
and WxxF motifs in protein binding, it is likely that NECAP2 function depends on 
the ability to link into a multi-component protein network specific to fast recycling 
and that interfering with individual binding sites is sufficient to impair AP-1-driven 
carrier formation. 
 
NECAP2 binding partners 
 To identify NECAP2 binding partners we originally performed GST pull-
down assays with NECAP1 and NECAP2. However, the NECAP2 binding 
partners identified also interact with NECAP1 and most have been linked to CME 
(37), suggesting that these interactions are not responsible for the pathway-
specific role of NECAP2. Since our GST pull-down assays used bait proteins 
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purified from bacteria that may miss post-translational modifications needed for 
interactions with other proteins. We expressed Flag-tagged NECAP1 and 
NECAP2 in mammalian cells in an attempt to isolate NECAP2-specific binding 
partners by co-immunoprecipitation (co-IP). We had to use expression of tagged 
proteins because there are currently no antibodies available for 
immunoprecipitation of endogenous NECAP2. Co-IP samples were resolved by 
SDS-PAGE and stained by Coomassie before bands were excised for protein 
identification by mass spectrometry in collaboration with Dr. Cathy Costello 
(Boston University School of Medicine). This approach again identified AP-1 and 
AP-2 as binding partners, with a high number of peptides detected, for both 
NECAP1 and NECAP2 (Table 3). In contrast, the remaining candidates were 
identified with only low peptide counts and included proteins known to bind 
NECAP1 and/or to function in CME, such as FCHo2. Moreover, the only 
candidate protein with a potential preference for NECAP2, Vps35, is not affected 
by NECAP2 depletion (Table 3). Thus, the Co-IP approach did not result in 
promising leads for proteins specific to the NECAP2 fast recycling pathway. 
Given the high degree of functional specificity for NECAP1 and NECAP2 in their 
respective pathways in intact cells, future experiments will have to identify 
binding partners under conditions where this pathway specificity of the NECAP 
family members is preserved.
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 NECAP1 NECAP2 
Adaptin binding partners 
  Protein 
ID MW 
Peptides 
identified 
Peptides 
identified 
AP-1 complex subunit beta-1 AP1B1 105 kDa 73 119 
AP-1 complex subunit gamma-1  AP1G1 91 kDa 49 79 
AP-1 complex subunit gamma-like 2  AP1G2 87 kDa 19 19 
AP-1 complex subunit mu-1  AP1M1 49 kDa 35 21 
AP-2 complex subunit mu  AP2M1 50 kDa 19 15 
AP-2 complex subunit alpha-1  AP2A1 108 kDa 55 81 
AP-2 complex subunit alpha-2  AP2A2 104 kDa 66 91 
AP-2 complex subunit beta  AP2B1 105 kDa 74 107 
Vesicle related binding partners         
AP2-associated protein kinase 1  AAK1 104 kDa 2 6 
BMP-2-inducible protein kinase  BMP2K 129 kDa 2 3 
Clathrin heavy chain 1  CLTC 192 kDa 3 3 
Epidermal growth factor receptor substrate 15-like 1  EPS15L1 94 kDa 7 8 
F-BAR domain only protein 2  FCHO2 89 kDa 3 9 
Vacuolar protein sorting-associated protein 35  VPS35 92 kDa - 3 
Vesicle-fusing ATPase  NSF 83 kDa 2 4 
 
Table 2 - NECAP1 and 2 binding partners. List of binding partners identified for NECAP1 and NECAP2. Flag-
tagged NECAP1 or NECAP2 were expressed in HEK293T cells, immunoprecipitated, and incubated with additional 
cell lysate before being resolved by SDS-PAGE. Protein bands were excised and analyzed by mass spectrometry.  
 95 
NECAP2 regulates cell size and migration 
 We have previously shown that NECAP2/AP-1 control the fast recycling of 
EGFR, resulting in decreased receptor levels on the cell surface (128) that may 
affect cell behaviors regulated by EGFR such as cell size, proliferation, and cell 
motility (131–133). To test for changes in cell proliferation we pulsed control and 
NECAP2 KD cells with BrdU for 60 minutes and quantified the percentage of 
cells that incorporated the label during DNA synthesis by fluorescence imaging. 
This assay did not reveal a role for NECAP2 in the regulation of cell proliferation 
(Fig. 4.5A).  
We next tested for changes in cell growth since activation of the mTOR pathway 
downstream of EGFR contributes to cell metabolism and cell size (134). Control 
and NECAP2 KD cells were trypsinized and imaged in solution to measure cell 
diameter as a read-out of cell size independent of potential changes in cell 
spreading during adhesion. Interestingly, NECAP2 KD causes a significant 
increase in cell size (Fig. 4.5B) and future studies will determine the changes in 
cell signaling and metabolism underlying this phenotype.  
 We also tested for changes in cell migration using scratch wound 
healing assays. Control and NECAP2 KD cells were grown to confluency, 
scratched (t=0) and allowed to migrate until control cells were about to close the 
wound (t=11 hours). Notably, NECAP2 KD caused an approximately 50% 
decrease in cell migration (Fig. 4.5C). Closer inspection of the cells at the leading 
edge of the wound revealed a lack of lamellipodia-like protrusions in NECAP2 KD 
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Figure 4.5 - NECAP2 controls cell size and migration in MCF10A cells.  
(A) Quantification of BrdU cell proliferation assay of control and NECAP2 KD 
MCF10A cells. (B) Quantification of cell diameter from control and NECAP2 KD 
MCF10A cells trypsinized and imaged in suspension. (C) Quantification of the 
distance cells migrated in scratch wound assay for control and NECAP2 KD 
MCF10A cells displayed in (D). (A-C) N=3 experiments. Statistical analysis using 
One-Way ANOVA followed by Dunnett’s post-tests revealed significant 
differences between NECAP2 KD and control cells, * p=<0.05, ** p=<0.01, *** p= 
<0.001. (D) Transmitted light images of scratch wound assays for control and 
NECAP2 KD MCF10A cells as indicated. Left panels are imaged at 0 hours right 
after wounding and middle panels were taken 11 hours post wounding. Right 
panels are magnified images of the leading edge outlined by the black box in 
middle panels. Scale bar equals 200 µm in the left and middle panels, and 50 µm 
in the right panels. (E) Phalloidin staining of actin filaments for control and 
NECAP2 KD MCF10A cells 6 hours after wounding. Scale bar equals 20 µm.  
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cells compared to control (Fig. 4.5C). Since lamellipodia are areas of high actin 
dynamics, we labelled control and NECAP2 KD cells 6 hours after wounding with 
phalloidin to visualize actin fibers. These studies showed that the decrease in 
motility correlates with changes in actin organization at the front of the cells at the 
leading edge (Fig. 4.5D).  
Since actin dynamics driving lamellipodia formation is controlled by Rac1 
(124), we next tested if NECAP2 KD alters the activation state of Rac1. Effector 
pull-down assays to measure the levels of GTP-bound, active Rac1 revealed a 
significant decrease in Rac1 activation in NECAP2 KD cells compared to control 
(Fig. 4.6A,B). Together these data show that NECAP2-medaited fast recycling 
contributes to the regulation of essential cellular functions including cell growth 
and migration.  
 
NECAP2 is a general regulator of Rac1 activity 
The Rab4a fast recycling pathway has previously been linked to the 
regulation of Rac1 activity (45, 80, 135, 136). Specifically, growth-factor induced 
fast recycling of integrin αvβ3 to the leading edge results in localized Rac1 
activation and integrin β3-dependent cell migration in NIH3T3 and triple negative 
breast cancer (TNBC) MDA-MB-231 cells (73, 135) . We thus tested if NECAP2 
KD affected Rac1 activation levels in these cell lines. Indeed, NECAP2 KD 
resulted in a significant decrease in the levels of active Rac1 in both NIH3T3 
(Fig. 4.6C,D) and MDA-MB-231 (Fig. 4.5E,F) cells, consistent with our results in 
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Figure 4.6 - NECAP2 is required for Rac1 activation. (A,C,E) Western blot 
analysis of active Rac1 isolated from control and NECAP2 KD cells. Top panels 
show total Rac1 levels in total protein lysates from MCF10A (A), NIH3T3 (C), and 
MDA-MB-231 cells (E). Middle panel and bottom panels show Rac1 levels bound 
to GST alone (middle) or the PAK-CRIB effector domain (bottom) which 
selectively interacts with active Rac1. Arrows indicate Rac1. * indicates GST 
degradation product. (B,D,F) Quantification of (A,C,E) showing active Rac1 
levels compared to control cells, N=3 experiments. Statistical analysis using One-
Way ANOVA followed by Dunnett’s post-tests revealed significant differences 
between NECAP2 KD and control cells, ** p=<0.01, *** p= <0.001. 
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MCF10A cells. These data show that NECAP2 regulation of Rac1 activity is 
conserved across various cell types and suggests that NECAP2 may control 
integrin αvβ3-dependent cell migration.  
 
NECAP2 controls integrin αvβ3-driven cell migration 
 Growth factor stimulation of MDA-MB-231 cells promotes the Rab4a-
dependent recycling of integrin αvβ3, which results in persistent cell migration, 
while simultaneously inhibiting integrin α5β1 recycling along the slow recycling 
pathway and pro-migratory signaling (73). Moreover, blocking Rab4a-mediated 
integrin αvβ3 recycling relieves this inhibition and results in increased integrin β1 
recycling and integrin β1-driven migration (70, 80). To determine the role of 
NECAP2 in integrin αvβ3 fast recycling, we performed live cell imaging of scratch 
wound assays of control and NECAP2 KD cells plated on vitronectin, which 
engages integrin αvβ3, or fibronectin, which is a substrate for integrin αvβ3 and 
integrin α5β1 (79, 137). Therefore, any changes observed in cell migration on 
vitronectin coating can be directly attributed to changes in integrin αvβ3 
dynamics while altered migration on fibronectin can be due to changes integrin 
αvβ3 or integrin α5β1 turnover. NECAP2 depletion caused a decrease in total 
distance migrated and velocity of MDA-MB-231 cells on vitronectin by about 20% 
compared to control cells (Fig. 4.7A-C). Interestingly, NECAP2 KD did not alter 
the motility of cells on fibronectin (Fig. 4.7A-C). Further analysis of cell 
displacement on vitronectin revealed a reduction in persistent migration in  
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Figure 4.7 - NECAP2 controls integrin αvβ3-driven cell migration. (A) Cell 
migration plots of control and NECAP2 KD MDA-MB-231 cells. Cells were 
treated with 20 ng/ml PDGF-BB after overnight starvation. Lines indicate cell 
tracks analyzed by live cell imaging of a scratch wound assay at 10 minute 
increments over 5 hours. All tracks have been plotted to start at x = 0, y = 0, and 
oriented such that the wound gap is located in the bottom half of the plot 
(negative y values). Plates were coated with fibronectin or vitronectin as 
indicated. (B) Quantification of the mean total distance cells travelled in (A) on 
fibronectin and vitronectin coatings as indicated. (C) Quantification of the mean 
velocity of cells migrated in (A) on fibronectin and vitronectin as indicated. (B,C) 
N=3 experiments, n=60 cells total per group. Statistical analysis using Two-Way 
ANOVA followed by Bonferroni post-tests revealed significant differences 
between NECAP2 KD and control cells, *** p= <0.001. (D) Quantification of the 
number of cells categorized by distance between start and end point 
(displacement) of migration on vitronectin-coated surfaces over the length of the 
experiment. Cells were binned in 30 µm increments. (E) Cumulative distribution 
of displacement of control and NECAP2 KD cells migrating on vitronectin-coated 
surfaces. Lines indicate final displacement for 50% of control (green) and 
NECAP2 KD (KD1: black, KD2; red) cells.  
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NECAP2 KD cells (Fig. 4.7D,E). Binning of the displacement of migratory cells 
showed that the majority of NECAP2 KD cells moved no more than 60 µm from 
their point of origin while control cells showed a more even distribution of number 
of cells over a distance of up to 150 µm (Fig, 4.7D). In addition, the cumulative 
distribution of displacement shows 50% of NECAP2 KD cells reach a 
displacement of only approximately 53 µm, while 50% of controls cells reach a 
displacement of 85.4 µm (Fig. 4.7E). Notably, NECAP2 depletion causes a 
stronger decrease in displacement than in velocity and distance, demonstrating 
that NECAP2 KD cells migrate randomly on vitronectin coated substrates. This 
loss of persistent migration is consistent with the decrease seen when blocking 
Rab4a-mediated fast recycling by KD of PKD1 (78), and shows that 
NECAP2/AP-1-dependent fast recycling functions as a key pathway in the 
regulation of integrin αvβ3 recycling and integrin αvβ3-dependent cell migration. 
 
 Integrin β1 surface levels and signaling are increased upon NECAP2 
depletion 
We next sought to determine if NECAP2 function is also required for the 
regulatory cross-talk between RAb4a-driven fast recycling of integrin αvβ3 and 
the Rab11-driven slow recycling of integrin α5β1. Previous studies have shown 
that impeding fast recycling of integrin αvβ3 through expression of constitutively 
inactive Rab4a or by Rabaptin-5 KD increases integrin α5β1 recycling (70, 78) as 
well as downstream signaling events for integrin α5β1-dependent random cell  
 105 
 
 
Figure 4.8 - NECAP2 KD increases integrin β1 cell surface levels and 
signaling. (A) Cell surface levels of integrin β3 and integrin β1 in control and 
NECAP2 KD MDA-MB-231 cells analyzed by surface biotinylation followed by 
capture-ELISA. (B) Western blot analysis of cofilin phosphorylation in control, 
NECAP2 KD, and Rab4a KD MDA-MB-231 cells. Top panel shows 
phosphorylated cofilin (serine 3) and bottom panel shows total cofilin levels. (C) 
Quantification of (B). (A,C) N=3 experiments. Statistical analysis using One-Way 
ANOVA followed by Dunnett’s post-tests revealed significant differences between 
control and NECAP2 or Rab4a KD cells, * p=<0.05, ** p=<0.01, *** p= <0.001. 
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migration (80, 81). Cell surface biotinylation of control and NECAP2 KD cells 
followed by capture-ELISA revealed that NECAP2 KD indeed results in a 
significant increase in integrin β1 surface levels while surface levels of integrin β3 
remained unchanged (Fig. 4.8A). In addition, we used Western blot analysis to 
test for the level of cofilin phosphorylation at serine 3, which is a key regulatory 
event in the signaling cascade downstream of integrin α5β1 (80) in control, 
NECAP2 KD, and Rab4a KD cells. These assays revealed that NECAP2 
depletion also increases integrin α5β1 signaling (Fig. 4.8B,C). Notably, Rab4a 
KD increases cofilin phosphorylation to a level similar to that resulting from 
NECAP2 KD (Fig. 4.8B,C), further supporting a central role of NECAP2 in 
Rab4a-dependent regulation of cell migration. Together, these data show that the 
NECAP2/AP-1 sub-route is the main pathway that controls the Rab4a-mediated 
switch between integrin αvβ3/Rac1-mediated persistent migration and integrin 
α5β1/RhoA-driven random migration.  
 
The NECAP2 pathway is required for cancer cell invasion 
Rab4a is amplified in up to 25% of breast cancers (72, 73) and Rab4a-
dependent recycling of integrin αvβ3 controls the invasive potential of breast 
cancer cells in vitro as well as metastasis in vivo (72, 73, 78). Because NECAP2 
is a key modulator of Rab4a-mediated integrin αvβ3 recycling and migration, and 
controls the Rab4a-driven migration of breast cancer cells, we sought to 
determine whether NECAP2 also controls breast cancer cell invasion in 3D in  
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Figure 4.9– NECAP2 is required for TNBC cell invasion. (A) Transmitted light 
images of 3D invasion assays for control, NECAP2 KD, and Rab4a KD LM2 cells 
seeded in matrigel gels or gels supplemented with 10 µg/ml fibronectin, as 
indicated. (B) Quantification of the degree of cell invasion in (A). Control, 
NECAP2 KD, and Rab4a KD cells were graded by shape/organization: highly 
invasive (colonies that spread far into the gel; green), invasive (colonies with 
limited invasion into the gel, sometimes containing a denser cell cluster; red), or 
spherical (round-shaped colonies with little or no cell extensions into the gel; 
blue). Bars represent the percentage of cells in each bin for each condition, N = 3 
experiments, 216-370 structures per condition, m: matrigel, m+f: fibronectin-
supplemented matrigel. Statistical analysis by Two-Way ANOVA followed by 
Bonferroni post-tests revealed significant differences between conditions, 
indicated in the figure as follows: asterisk (*) indicate significant differences 
between the corresponding bins of control and NECAP2 KD or Rab4a KD cells 
for cells seeded in matrigel, ** = p<0.01, *** = p<0.001; circles (O) indicate 
significant differences between the corresponding bins of control and NECAP2 
KD or Rab4a KD cells for cells seeded in fibronectin-supplemented matrigel, OOO 
= p<0.001; and triangles (Δ) indicate significant differences between the 
corresponding bins of cells transduced with the same virus and seeded in 
matrigel or fibronectin-supplemented matrigel, ΔΔ = p<0.01, ΔΔΔ = p<0.001. The 
statistical analysis did not reveal significant differences for the distribution of cells 
in the three bins for control cells seeded in matrigel or fibronectin-supplemented 
matrigel. In addition, no significant changes were detected when comparing the 
bin distribution between NECAP2 KD and Rab4a KD cells seeded in matrigel, or 
between NECAP2 KD and Rab4a KD cells seeded in fibronectin-supplemented 
matrigel.  
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vitro invasion assays, using a derivative of the MDA-MB-231 cell line, LM2, that 
are highly invasive and were isolated based on their ability to metastasize to the 
lung in mice (138). Single cell suspensions of control, NECAP2 KD and Rab4a 
KD cells were embedded in growth factor-reduced matrigel, which does not 
contain fibronectin and thus does not allow for integrin α5β1-mediated invasion. 
Transmitted light images of the gels were collected to determine cell invasion into 
the gel over time.  
Over nine days in culture, as expected, control cells invaded far into the 
gel (Fig. 4.9). In contrast, NECAP2 KD cells grew into spherical colonies that 
show only limited or no invasion into the surrounding cells (Fig. 4.9), 
demonstrating the NECAP2-mediated fast recycling also controls integrin αvβ3-
driven cancer cell invasion in vitro. Notably, NECAP2 KD and Rab4a KD had a 
comparable effect on cell invasion (Fig. 4.9), highlighting that the NECAP2/AP-1 
sub-route serves as the major pathway responsible for Rab4a-controlled 
migration and invasion.  
When the Rab4a pathway is inactivated, cells switch from integrin β3- to 
integrin β1-dependent extracellular matrix engagement (78). Since NECAP2 KD 
releases the inhibition on integrin α5β1 along the slow recycling pathway, leading 
to increased integrin α5β1 surface levels and signaling, we supplemented the 3D 
gels with fibronectin, which allows for integrin α5β1-driven invasion. As before, 
control cells invaded deep into the gel (Fig. 4.9). However, addition of fibronectin 
allowed both NECAP2 KD and Rab4a KD cells to regain their invasive potential, 
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demonstrating that integrin α5β1-mediated invasion remains functional when fast 
recycling is impaired. As before, NECAP2 KD cells mimic the effect seen with 
Rab4a KD cells (Fig. 4.9), consistent with our data that NECAP2 KD and Rab4a 
KD also cause a comparable increase in integrin α5β1 signaling (Fig. 4.8B,C). 
Notably, NECAP2 KD and Rab4a KD cells do not display the same levels of 
invasiveness that is seen for control cells. This difference likely can be attributed 
to the fact that in the fibronectin-supplements gels, control cells are still able to 
migrate in an integrin αvβ3-dependent manner as well. In contrast, KD cells have 
to rely on integrin α5β1-mediated invasion alone. Together, our data demonstrate 
that the NECAP2 pathway is the main route regulating Rab4a-dependent breast 
cancer cell invasion and provide further support for the role of NECAP2 as a 
central regulator in the Rab4a fast recycling pathway 
 
Discussion 
 The Rab4a fast recycling pathway controls a wide range of cellular 
functions and shows a unique level of complexity, with multiple clathrin adapters 
and retromer components functioning as downstream effectors of Rab4a. 
Several of these effectors have been linked to the recycling of specific cargo (40, 
45, 67). However, the additional roles of the Rab4a effector proteins in cargo 
transport in between endosomes and the Golgi have hampered the design of 
experimental approaches to selectively impede their function at EEs. Thus, it 
remains an open question whether the various Rab4a effector proteins are 
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functionally redundant or define individual sub-routes that recycle select sets of 
cargo and/or regulate specific cellular behavior and functions. Our data show that 
NECAP2 function is essential for AP-1-mediated fast recycling, while NECAP2 
does not affect the recruitment of other Rab4a effectors to EEs. Importantly, 
NECAP2 is also not involved in AP-1 recruitment to the Golgi and thus offers a 
unique opportunity to selectively manipulate one individual sub-route within the 
Rab4a fast recycling pathway.  
Through a GTPase cascade, Rab4a triggers the generation of active, 
GTP-bound Arf1 and Arf3 on EEs, which then serve as docking sites for clathrin 
adapter recruitment (44). Since NECAP2 KD only impairs AP-1 recruitment to 
EEs and our studies with the Arf inhibitor BFA demonstrate that AP-3 is still 
recruited to EEs in an Arf1/Arf3-dependent manner in NECAP2 KD cells, 
NECAP2 likely functions in later steps of AP-1 recycling carrier formation. Our 
rescue studies revealed that NECAP2 function depends on the ability of the N-
terminal PH domain to bind to FxDxF motif containing proteins (128). Moreover, 
a NECAP chimera in which the PH domain of NECAP2 was replaced with that of 
NECAP1 fails to rescue NECAP2 KD cells, suggesting that NECAP2 interacts 
with and potentially recruits FxDxF peptide motif-containing proteins during 
recycling carrier formation. However, our attempts to gain more insights into the 
protein machinery controlling AP-1-mediated fast recycling by identifying 
NECAP2-specific binding partners have thus far been unsuccessful. Given the 
exclusive roles for NECAP1 in CME and NECAP2 in fast recycling, future 
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attempts will have to take advantage of the pathway specificity seen in intact 
cells.  
We have previously shown that NECAP2 regulates the fast recycling of 
EGFR and TfnR (128), consistent with the role of the AP-1/Rab4a pathway in fast 
TfnR recycling (40). EGFR and TfnR both accumulated in EEs due to impaired 
fast recycling in NECAP2 KD cells (128). However, NECAP2 KD has different 
effects on the expression of these cargo. EGFR expression levels remained 
unchanged between control and NECAP2 KD cells, resulting in a decrease in 
EGFR levels at the cell surface. In contrast, NECAP2 KD cells showed an 
increase in TfnR expression such that surface levels remained comparable to 
control cells (128). A similar response may explain the comparable levels of β3-
integrin at the cell surface seen for control and NECAP2 KD cells, even though 
we were not able to confirm an increase in β3-integrin expression levels due to a 
lack of antibodies for detection by Western blot. NECAP2 depletion phenocopies 
the key effects of impaired integrin αvβ3 recycling, including impaired migration 
on vitronectin (139), decreased Rac1 activity and increased β1-integrin surface 
levels and signaling (80), and thus, the NECAP2/AP-1 sub-route is likely the 
main pathway to control integrin αvβ3-dependent cell migration. Importantly, our 
data demonstrate that manipulation of NECAP2 is sufficient to regulate this sub-
route and alter integrin αvβ3-driven cell migration as well as cancer cell invasion 
in vitro. It will be interesting to see if loss of NECAP2 function also impairs cancer 
cell invasion and metastasis in vivo. If so, the NECAP2/AP-1 sub-route may 
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provide a new therapeutic target, in particular for breast cancers with 
amplification of Rab4a and β3-integrin. 
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 CHAPTER V –GENERAL DISCUSSION AND FUTURE DIRECTIONS 
Divergence of NECAP1 and NECAP2. 
The NECAP protein family consists of two family members, NECAP1 and 
NECAP2, that in mouse share 60% sequence identity and 73% sequence 
similarity overall. NECAP1 and NECAP2 show the highest degree of divergence 
in their C-terminal regions. However, this region contains two highly conserved 
WxxF-type peptide motifs, DxWGDF and WVQF-COO-, that interact with the γ-
ear of AP-1 and the sandwich sub-domain of the AP-2 α-ear, respectively (83, 
86, 87). Interestingly, biochemical assays such as GST pull down assays and co-
immunoprecipitations consistently showed comparable binding of AP-1 and AP-2 
to their corresponding motifs in NECAP1 and NECAP2, whether the motifs were 
in isolation or in the context of the respective full-length proteins (83, 86). Yet, 
NECAP1 functions exclusively with AP-2 in CME (84) while the data presented 
here demonstrate that NECAP2 selectively regulates AP-1 carrier formation on 
EEs. In addition, each NECAP fails to rescue the KD phenotype of the other 
family member (84, 128), suggesting that other regions within the NECAP protein 
sequences create pathway-specific function.   
In their N-terminal region, murine NECAP1 and NECAP2 share 75% 
sequence identity and 88% sequence similarity. The NECAP PH domain, which 
is located at the beginning of the conserved N-terminal regions, shows an even 
higher degree of conservation between NECAP1 and NECAP2 (82% identity, 
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93% similarity) (83). Yet, a NECAP chimera in which the NECAP2 PH domain 
was replaced by that of NECAP1, fails to rescue AP-1 recruitment to EEs.  
The NECAP PH domain functions as a protein binding module and 
interacts with proteins that display FxDxF peptide motifs (37, 84). FxDxF motifs 
were originally identified as binding motifs for the platform domain of the AP-2 α-
ear and the ability of the NECAP PH domain to interact with the peptide motif is 
surprising, especially since the NECAP PH fold and the AP-2 α-ear share no 
sequence or structural similarity (37, 83). Similar to the situation with the two 
WxxF-type motifs in the NECAP C-terminus, in vitro protein binding studies have 
identified a large overlap in FxDxF motif containing binding partners between 
NECAP1 and NECAP2 (37). Yet, as mentioned above, the chimera containing 
the NECAP1 PH domain fails to rescue to NECAP2 KD phenotype. In addition, a 
NECAP2 variant with a single point mutation in the PH domain that blocks FxDxF 
motif-dependent interactions also fails to rescue, demonstrating that NECAP2 
interactions with FxDxF motif-containing proteins is essential for AP-1 recycling 
carrier formation and AP-1-dependent fast recycling.   
One possible explanation for our results is that in addition to the binding 
site for FxDxF motifs, the NECAP2 PH domain contains an additional functional 
interface that is not conserved in NECAP1. However, we currently have no 
experimental data that would support this hypothesis and the high degree of 
sequence conservation between the PH domains of NECAP1 and NECAP2 
makes it hard to envision that the NECAP2 PH domain could have gained an 
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additional, unique function. A more likely explanation may be that NECAP1 and 
NECAP2 interact with different sets of FxDxF motif-containing binding partners 
and that these interactions are necessary for the pathway-specific role of each 
NECAP. In fact, previous pull-down assays showed that while NECAP1 and 
NECAP2 shared a lot of binding partners associated with the endocytic protein 
machinery, NECAP2 showed weaker binding (37). The difference in binding 
affinity may be due to the sequence variations between the NECAP PH domains 
and interestingly, five of the amino acid positions not conserved between 
NECAP1 and NECAP2 are located in or near the FxDxF motif binding site.  
However, our numerous attempts to identify NECAP2-specific protein 
binding partner were thus far unsuccessful, with candidates interacting with 
NECAP1 to a similar degree and/or being solidly linked to CME. It thus seems 
that the functional specificity of NECAP1 and NECAP2 seen in intact cells is lost 
when using cell lysates in biochemical assays. One approach that may allow to 
define the interactomes of NECAP1 and NECAP2 under physiological conditions 
is the use of BioID with a promiscuous biotin ligase. For this assay, each NECAP 
family member would be fused to a promiscuous variant of the biotin ligase BirA, 
which is able to transfer the biotin label on any protein independent of the 
presence of a specific target sequence. During the biotin pulse, any NECAP 
binding partners coming into close enough proximity would be labeled with biotin, 
which could then be used to affinity purify these candidates for identification by 
mass spectrometry.  
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A caveat of the promiscuous BioID approach is that overexpression of 
NECAPs causes binding partners to become mislocalized, which is likely to skew 
results. For example, our rescue studies depended on IF to threshold NECAP 
expression levels and to exclude high expressing cells, in which binding partners 
such as AP-1 and AP-2 may lose their membrane association, from the analysis. 
Thus, it would be best to use CRISPR/Cas9-mediated genome editing to tag 
NECAP1 and NECAP2 with BirA such that the fusion protein are expressed at 
endogenous levels. Elucidation of the protein network built around NECAP1 and 
NECAP2 at their site of action will provide information on how each family 
member controls a specific trafficking pathway despite the large degree of shared 
features. 
 
Functional model of NECAP2 
During CME, NECAP1 and AP-2 cooperate with each other to recruit 
endocytic accessory proteins to the forming vesicle sites to promote successful 
vesicle formation (84). Specifically, through its C-terminal WxxF-acidic motif, 
NECAP1 binds to the sandwich subdomain of the AP-2 α-ear. This brings the 
NECAP1 PH domain into the proximity of the platform subdomain of the α-ear, 
which both interact with FxDxF motifs, thereby increasing the affinity for FxDxF 
motif protein recruitment into the forming clathrin coat (Fig. 1.3) (84). In the 
absence of NECAP1, AP-2 maintains the organization of the endocytic protein 
machinery, however, the decreased recruitment of FxDxF motif-containing 
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proteins such as AP180/CALM and FCHo1/2 alters the number, size and cargo 
content of the vesicles formed (84).  
The NECAP1 PH domain, together with extended N-terminal region 
(PH/Ex), also interacts with AP-2. This second binding site has been mapped to 
the AP-2 β2-linker and overlaps with the clathrin binding box such that NECAP1 
and clathrin compete with each other for access (84). In addition, the interface for 
β2-linker binding in the PH domain overlaps with the binding site for FxDxF 
motifs (84) and thus, PH/Ex binding to the β2-linker likely prevents interactions 
with endocytic accessory proteins. Together, these interactions suggests that 
NECAP1 and AP-2 form two different complexes. In the first, NECAP1 to AP-2 α-
ear (WxxF-acidic motif) as well as to the β2-linker (PH/Ex) in a closed 
conformation that limits interactions with clathrin and accessory proteins and 
therefore, like represents a pre-endocytic complex. During vesicle formation, 
clathrin would compete PH/Ex off the β2-linker, resulting a second, open 
conformation complex in which the PH domain and α-ear cooperate in accessory 
protein recruitment (Fig. 1.6) (84). 
Our functional characterization of NECAP2 supports the idea that 
NECAP2 and AP-1 interact in a similar fashion. NECAP2 binds to the AP-1 γ-ear 
through the second WxxF-type peptide motif in its C-terminus (86, 128) and our 
preliminary studies (data not shown) indicate that the NECAP2 PH/Ex region 
interacts with AP-1 similar to the interaction seen for NECAP1 and AP-2. 
Moreover, the clathrin box motif as well as the surrounding sequence are 
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conserved between the β2- and β1-linker. Thus, it is likely that NECAP2 and AP-
1 also form a closed conformation complex that could limit clathrin binding to the 
β1-linker and accessory protein interactions of the NECAP2 PH domain prior to 
carrier formation (Fig. 5.1).  
Notably, the open conformation complex would allow for NECAP2 to 
recruit FxDxF motif-containing accessory proteins to EEs to promote successful 
recycling carrier formation (Fig. 5.1). Since the AP-1 γ-ear lacks the FxDxF 
binding region of the AP-2 α-ear, NECAP2 may provide the only means for AP-1 
to engage accessory proteins containing this motif, suggesting that NECAP2 
plays a central role in the composition and organization of the protein machinery 
driving recycling carrier formation.   
 
Role of NECAP2 in AP-1-mediated recycling carrier formation 
Our knockdown studies showed that NECAP2 is essential for recruitment 
of AP-1 to EE and for AP-1-mediated fast recycling. However, the means by 
which NECAP2 controls AP-1 recruitment has yet to be identified. AP-1 
recruitment to the Golgi is known to depend on interactions with active Arf1 (130, 
140–142), cargo (130, 143, 144), and PI(4)P (130, 145, 146), each of which 
serve as a docking site for AP-1 on the Golgi membrane. Recruitment of AP-1 to 
EEs is less well understood. Although PI(4)P has been reported at endosomes 
(147, 148), its role in AP-1 recruitment to EEs remains undefined. Notably, we 
have demonstrated that NECAP2 KD results in an accumulation of AP-1-  
 120 
 
 
 
 
 
Figure 5.1 – Model of NECAP2 and AP-1 interactions. Based on the model of 
NECAP1 and AP-2 function in CME, NECAP2 and AP-1 may form two 
functionally distinct complexes. In the first, the WxxF-type motif in the NECAP2 
C-terminus binds to the AP-1 γ-ear while the PH/Ex region binds to a site in the 
β1-linker that overlaps with the clathrin binding site (left). This closed 
conformation would limit the access of clathrin and FxDxF motif-containing 
accessory proteins to the NECAP2/AP-1 complex. During carrier formation, 
clathrin could compete PH/Ex off the linker, creating an open conformation 
complex that allows for clathrin polymerization and recruitment of FxDxF motif-
containing proteins into the protein machinery for carrier formation (right). 
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dependent cargo such as TfnR in EEs, yet, AP-1 is lost from the compartment. 
Thus, cargo is not sufficient to drive AP-1 carrier formation at EEs in the absence 
of NECAP2.  
In contrast, Arf1 is known to regulate AP-1 recruitment to EEs downstream 
of Rab4a (44). We have shown that NECAP2 depletion does not alter the 
recruitment of other Arf1-dependent clathrin adaptors to EEs. Furthermore, 
inhibition of Arf1 activation with BFA causes the clathrin adapter AP-3, which 
depends on Arf1, to dissociate from endosomes in control as well as NECAP2 
KD cells, demonstrating that EEs in NECAP2 KD cells contain sufficient levels of 
active Arf1 to maintain clathrin adaptor recruitment. These data place NECAP2 
downstream of Arf1 regulation and suggest that NECAP2 regulates the formation 
of the AP-1/clathrin coat for recycling carrier formation similar to the role of 
NECAP1 in CME (Fig. 5.2). 
During endocytosis, NECAP1 cooperates with AP-2 to recruit accessory 
proteins to the plasma membrane for efficient vesicle formation (84). Depletion of 
NECAP1 imbalances the endocytic protein network and impairs the number and 
size of vesicles formed (84). However, AP-2 still functions at the plasma 
membrane in NECAP1 KD cells, which is in contrast to the loss of AP-1 from EEs 
in NECAP2 KD cells. This difference suggests that the AP-1-mediated fast 
recycling pathway is more sensitive to changes in NECAP levels. Dependence 
on a single component such as NECAP2 may indicate that the protein machinery 
for recycling carrier formation is less complex than the protein network regulating  
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Figure 5.2– NECAP2 controls AP-1-mediated recycling carrier formation 
downstream of Rab4a. Model of Rab4a-mediated recycling from EEs 
highlighting the various Rab4a effector proteins and some of their known cargo.  
Arf1 is active in Rab4a-positive early endosomal subdomains and provides a 
platform for clathrin adaptor recruitment. NECAP2 controls AP-1 recruitment 
downstream of Arf1 for the recycling of integrin αvβ3, EGFR, and TfnR. In 
contrast, NECAP2 does not regulate GGA3- or Vps35-mediated recycling. 
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endocytosis. However, given that carrier formation likely requires many of the 
steps involved in CME, including cargo selection, membrane deformation, coat 
formation and carrier scission, one would expect the protein machinery driving 
carrier formation to show a complexity similar to that required for endocytic 
vesicle formation.  
Another intriguing possibility is that NECAP2-mediated recruitment of 
FxDxF motif containing accessory proteins is essential for AP-1 carrier formation. 
As mentioned above, the FxDxF motif binding site in the AP-2 α-ear is not 
conserved in AP-1. Thus, NECAP2 may provide the only means to bring FxDxF 
motif containing proteins into the protein network driving recycling carrier 
formation. Indeed, our rescue studies demonstrate that NECAP2 function 
depends on the ability of the PH domain to interact with FxDxF motif-containing 
binding partners. 
Recent advances in live cell imaging reveal that during the early steps of 
endocytic vesicle formation, AP-2 and clathrin transiently interact with the 
membrane with high on/off dynamics (11, 12, 99). For productive vesicle 
formation, these initial interactions need to be further stabilized through the 
recruitment of accessory proteins and cargo that allow the protein network to 
grow into the clathrin coat. It is likely that AP-1-mediated carrier formation also 
transitions from initial, short-lived recruitment of AP-1 to EE and the subsequent 
growth and stabilization of the AP-1 coat. Our IF based analysis of AP-1 on EEs 
lacks the sensitivity of the single molecule live cell studies used to analyze the 
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initial steps of AP-2 recruitment to the plasma membrane. Thus, the loss of AP-1 
from EEs that we observe in the NECAP2 KD cells could be the result of either 
impaired AP-1 docking to the membrane or failure of the protein network to 
expand into the carrier coat.  
Since the imaging technology used for AP-2 studies is not yet 
commercially available, one method to determine if NECAP2 regulates early AP-
1 recruitment or late steps during coat formation is targeted BioID. This method 
uses a biotin ligase, which covalently attaches biotin to a defined target 
sequence called AviTag when the ligase and tag come into close enough 
proximity (149). To define the role of NECAP2 in AP-1 carrier formation, the 
AviTag could be fused to a subunit of AP-1 and previous studies have shown that 
fusion of similar sized tags to the µ1-adaptin subunit did not alter AP-1 function 
(112). On the other hand, the biotin ligase would be targeted to sites of recycling 
carrier formation, e.g. by fusion to Rab4a. In the presence of biotin, the ligase 
would then biotin label AP-1 whenever it is recruited to EEs. Comparison of the 
AP-1 biotinylation levels and the distribution of the labelled AP-1 between the 
cytosolic and membrane fraction in control and NECAP2 KD cells will allow to 
determine if the NECAP2 functions in carrier formation during initial AP-1 
recruitment to EE or in the stabilization of the protein coat on the membrane. 
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Functional diversity within the Rab4a fast recycling pathway 
Rab4a-mediated fast recycling controls the direct recycling of numerous 
receptors and regulates several cellular functions including nutrient uptake, cell 
signaling and cell migration (45, 50, 150). Rab4a controls the recycling of a 
diverse set of cargo (45, 67, 70, 75, 96, 151) and a unique feature of the Rab4a 
fast recycling pathway is the recruitment of a variety of effector proteins, 
including the clathrin adapters AP-1, AP-3 and GGA3 as well as the retromer 
component Vps35.  
Several effector proteins have been linked to the recycling of specific 
cargo. For example, Rab4a/AP-1 control the fast recycling of TfnR while 
Rab4a/GGA3 regulate Met receptor recycling in response to HGF stimulation and 
Rab4a/Vps35 govern β2-adrenergic receptor recycling (40, 45, 67). Thus far, the 
tools available for manipulating the Rab4a fast recycling pathway would either 
affect the complete set of downstream effectors or interfere with effector protein 
function at EEs as well as the Golgi. As a results, it still remains unclear whether 
the different effector proteins share a redundant role in fast recycling or whether 
they create individual sub-routes that serve in the regulation of distinct sets or 
cargo and cellular functions.  
Our studies demonstrated that NECAP2 selectively controls AP-1 function 
on EEs. NECAP2 KD results in a loss of AP-1 from early endosomes but does 
not affect the recruitment of the other effectors proteins downstream of Rab4a. In 
addition, NECAP2 KD does not inhibit AP-1 recruitment to the Golgi. Thus, 
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NECAP2 provides a unique opportunity to begin to define the degree of 
functional diversity within the Rab4a fast recycling pathway. Side-by-side 
characterization of control, NECAP2 KD and Rab4a KD cells will allow to tackle 
the question if the different Rab4a effector proteins control the recycling of 
distinct sets of cargo and/or regulate specific cell behavior.  
The data presented here revealed that the NECAP2/AP-1 sub-route is 
essential for the fast recycling of TfnR, EGFR and integrin β3. However, it is 
likely that NECAP2/AP-1 control additional cargo that are recycled through the 
Rab4a-mediated pathway. Notably, depletion of NECAP2 results in decreased 
EGFR surface levels. In contrast, NECAP2 KD cells maintain TfnR surface levels 
similar to control cells, however, this requires a significant upregulation in total 
TfnR protein levels. Thus, a quantitative mass spectrometry analysis of the cell 
surface and total proteome of control, NECAP2 KD and Rab4 KD cells will allow 
to identify additional candidate cargo for which relative surface levels decrease. 
These studies will provide first insights into the degree of cargo specificity within 
the Rab4a pathway and may offer additional leads into the role of NECAP2/AP-1-
mediated fast recycling in cell physiology.  
  
NECAP2 function regulates cell size, migration and cancer cell invasion 
Receptor recycling is a key regulator of receptor signaling downstream of 
receptor tyrosine kinases (RTKs) and thus impacts a wide range of cellular 
functions including cell proliferation and growth, differentiation, migration and 
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cancer cell invasion and metastasis (9, 45, 67, 131, 152–154). Early endosomes 
have recently been identified as a signaling platform for RTKs, providing a 
mechanism for changes in signaling upon altered receptor recycling. Signaling 
components of the mitogen-activated protein kinases (MAPK) signaling cascade, 
such as Grb2, SOS, and Raf, are active at endosomes downstream of RTKs 
(155, 156). However, regulation of such signaling cascades by receptor recycling 
is a complex process that can have varying effects. For example, the GGA3 
mediated recycling of Met receptor is needed for continued ERK1/2 
phosphorylation after HGF stimulation. The sustained signaling resulting from 
GGA3-mediated recycling drives cell migration and promotes a state of EMT 
(45).  
In contrast, inhibition of RTK recycling can also cause an increase in 
signaling. For cancer cells, decreased receptor recycling is a compensatory 
mechanism employed in hypoxia to increase signaling for improved survival and 
growth (9). Under low oxygen conditions the Rab effector protein rabaptin-5 is 
transcriptionally repressed, leading to retention of EGFR in EEs (9, 157). This 
causes prolonged activation of ERK1/2 and PI3K/Akt downstream of EGFR, 
allowing for continued cell proliferation (157).  
Our studies revealed a role for NECAP2 in cell growth regulation since 
NECAP2 KD results in a significant increase in cell size, however, the underlying 
mechanisms currently remains unknown. EGFR is known to control cell size 
through the PI3K-Akt-mTOR signaling pathway (131). The activation of mTOR by 
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Akt causes the phosphorylation of S6K1, resulting in increased mRNA and 
protein synthesis, contributing to increased cell size (134, 158). We have shown 
that NECAP2 KD impairs EGFR recycling and results in receptor accumulation in 
EEs. Thus, it will be interesting to determine if accumulation of EGFR within EEs 
alters EGFR signaling and whether the increase in cell size seen in NECAP2 KD 
cells  results from increased Akt-mTOR-S6K1 signaling in response to EGF.  
Notably, the data presented here identify the NECAP2/AP-1 fast recycling 
sub-route as a key pathway for the recycling of integrin ανβ3 and the regulation 
integrin ανβ3-dependent cell migration in response to stimulation with growth 
factors, including PDGF. NECAP2 KD recapitulates the changes in integrin ανβ3-
mediated migration and signaling observed when interfering directly with Rab4a 
function or downstream PKD1 signaling events (77, 78). Thus, NECAP2/AP-1-
mediated fast recycling thus controls signaling, actin dynamics and cell migration 
downstream of integrin ανβ3.  
In addition to integrin ανβ3 recycling, the Rab4a pathway also controls the 
recycling of ligand-stimulated PDGFR (75). It will be interesting to see whether 
the NECAP2/AP-1-mediated recycling sub-route also regulates PDGFR 
recycling, which may affect PDGF signaling upstream of integrins and create a 
positive feedback loop to further enhance growth-factor-induced cell migration.  
Rab4a and integrin β3 are amplified in several cancers including breast 
cancer, contributing directly to cancer cell migration and invasion in vitro as well 
as cancer metastasis in vivo (72, 78). Moreover, inactivation of Rab4a decreases 
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the metastatic potential of cancer cells in vivo largely due to changes in integrin 
β3 recycling (72, 73). Consistent with a major role for NECAP2/AP-1 fast 
recycling sub-route in integrin ανβ3-driven cell migration, NECAP2 KD impairs 
the invasion behavior of TNBC cells in a 3D invasion model. It is thus tempting to 
speculate that loss of NECAP2 function would also impair Rab4a/integrin ανβ3-
driven cancer cell invasion and metastasis in vivo.  
At this point, we cannot exclude the possibility that blocking NECAP2/AP-
1-mediated recycling may alter signaling of cargo RTKs and result in unwanted 
pro-invasive and pro-metastatic cell responses. However, loss of Rab4a function 
decreases cancer ceIls metastasis in vivo (72, 73), suggesting that the benefits 
of blocking fast recycling outweigh potential detrimental effects. Orthotopic 
implantation of control and NECAP2-depleted TNBC cells into the mammary fat 
pad of immunocompromised mice would allow to follow primary tumor growth 
and metastasis over time and provide a first indication if NECAP2 should be 
considered a potential therapeutic target.  
Given the pathway-specific function of NECAP1 and NECAP2 and the fact 
that NECAP1 and NECAP2 share no sequence similarity with other known 
proteins, small molecule inhibitors that selectively inhibit NECAP2 function, e.g. 
by exploiting the small sequence differences between the FxDxF motif interfaces 
in the PH domains of NECAP1 and NECAP2, may provide a promising avenue 
for the development of new therapeutic treatment options, in particular for breast 
cancers with amplification of Rab4a and β3-integrin. 
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Conclusion 
In the preceding chapters, I have presented data defining the previously 
uncharacterized protein NECAP2 as a key regulator of fast endocytic recycling. 
Importantly, my studies identify NECAP2 as the first protein known to selectively 
regulate a specific recycling route within the highly complex Rab4a recycling 
pathway and demonstrate that NEAP2-driven recycling serves as the main 
pathway to control integrin ανβ3-dependent cell migration and cancer cell 
invasion. Furthermore, I have demonstrated that the two members of the NECAP 
protein family have functionally diverged to regulate clathrin-mediated sorting 
events at distinct cellular locations and provide a first characterization of the 
molecular determinants for the pathway-specific function of NECAP2. Together, 
my studies have revealed NECAP2 as a unique tool to gain new insights into the 
molecular mechanisms that control the ill-defined Rab4a fast recycling pathway 
and to define the role of NECAP2-dependent recycling in cell physiology and 
pathology. 
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